BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. Front Immunol 2018;9:847. [PMID: 29780381 DOI: 10.3389/fimmu.2018.00847] [Cited by in Crossref: 277] [Cited by in F6Publishing: 276] [Article Influence: 69.3] [Reference Citation Analysis]
Number Citing Articles
1 Castro F, Pinto ML, Almeida R, Pereira F, Silva AM, Pereira CL, Santos SG, Barbosa MA, Gonçalves RM, Oliveira MJ. Chitosan/poly(γ-glutamic acid) nanoparticles incorporating IFN-γ for immune response modulation in the context of colorectal cancer. Biomater Sci 2019;7:3386-403. [PMID: 31233057 DOI: 10.1039/c9bm00393b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
2 Wang Q, Xie B, Liu S, Shi Y, Tao Y, Xiao D, Wang W. What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy? Front Immunol 2021;12:773168. [PMID: 35003090 DOI: 10.3389/fimmu.2021.773168] [Reference Citation Analysis]
3 Chen P, Tang Y, He W, Yang R, Lan Z, Chen R, Zhang P, Yokota S. Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/7137900] [Reference Citation Analysis]
4 Hua ZD, Liu XB, Sheng JH, Li C, Li P, Cai XQ, Han ZQ. UBE2V2 Positively Correlates With PD-L1 Expression and Confers Poor Patient Survival in Lung Adenocarcinoma. Appl Immunohistochem Mol Morphol 2021. [PMID: 33734107 DOI: 10.1097/PAI.0000000000000928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nath A, Cosgrove PA, Mirsafian H, Christie EL, Pflieger L, Copeland B, Majumdar S, Cristea MC, Han ES, Lee SJ, Wang EW, Fereday S, Traficante N, Salgia R, Werner T, Cohen AL, Moos P, Chang JT, Bowtell DDL, Bild AH. Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer. Nat Commun 2021;12:3039. [PMID: 34031395 DOI: 10.1038/s41467-021-23171-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Amens JN, Bahçecioglu G, Zorlutuna P. Immune System Effects on Breast Cancer. Cell Mol Bioeng 2021;14:279-92. [PMID: 34295441 DOI: 10.1007/s12195-021-00679-8] [Reference Citation Analysis]
7 Vargas-Diaz D, Altelaar M. Automated High-Throughput Method for the Fast, Robust, and Reproducible Enrichment of Newly Synthesized Proteins. J Proteome Res 2021. [PMID: 34860524 DOI: 10.1021/acs.jproteome.1c00743] [Reference Citation Analysis]
8 Pekar L, Klausz K, Busch M, Valldorf B, Kolmar H, Wesch D, Oberg HH, Krohn S, Boje AS, Gehlert CL, Toleikis L, Krah S, Gupta T, Rabinovich B, Zielonka S, Peipp M. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement. J Immunol 2021;206:225-36. [PMID: 33268483 DOI: 10.4049/jimmunol.2001004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Shukla A, Cloutier M, Appiya Santharam M, Ramanathan S, Ilangumaran S. The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy. Int J Mol Sci 2021;22:1964. [PMID: 33671123 DOI: 10.3390/ijms22041964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Onwuha‐ekpete L, Fields GB. Application of a triple‐helical peptide inhibitor of MMP ‐2/ MMP ‐9 to examine T‐cell activation in experimental autoimmune encephalomyelitis. Peptide Science. [DOI: 10.1002/pep2.24262] [Reference Citation Analysis]
11 Takahara T, Satou A, Ishikawa E, Kohno K, Kato S, Suzuki Y, Takahashi E, Ohashi A, Asano N, Tsuzuki T, Nakamura S. Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort. Virchows Arch 2021;478:541-52. [PMID: 32803453 DOI: 10.1007/s00428-020-02901-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance. Onco Targets Ther 2020;13:6037-50. [PMID: 32606809 DOI: 10.2147/OTT.S256708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Nasti TH, Yusuf N, Sherwani MA, Athar M, Timares L, Elmets CA. Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas. Cancer Prev Res (Phila) 2021;14:165-74. [PMID: 33148679 DOI: 10.1158/1940-6207.CAPR-20-0360] [Reference Citation Analysis]
14 Sahraei M, Chaube B, Liu Y, Sun J, Kaplan A, Price NL, Ding W, Oyaghire S, García-Milian R, Mehta S, Reshetnyak YK, Bahal R, Fiorina P, Glazer PM, Rimm DL, Fernández-Hernando C, Suárez Y. Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. J Clin Invest 2019;129:5518-36. [PMID: 31710308 DOI: 10.1172/JCI127125] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
15 Hanna A, Balko JM. Breast cancer resistance mechanisms: challenges to immunotherapy. Breast Cancer Res Treat 2021. [PMID: 34322780 DOI: 10.1007/s10549-021-06337-x] [Reference Citation Analysis]
16 Wijers CDM, Pham L, Menon S, Boyd KL, Noel HR, Skaar EP, Gaddy JA, Palmer LD, Noto MJ. Identification of Two Variants of Acinetobacter baumannii Strain ATCC 17978 with Distinct Genotypes and Phenotypes. Infect Immun 2021;89:e0045421. [PMID: 34460288 DOI: 10.1128/IAI.00454-21] [Reference Citation Analysis]
17 Cruz-Bermúdez A, Laza-Briviesca R, Casarrubios M, Sierra-Rodero B, Provencio M. The Role of Metabolism in Tumor Immune Evasion: Novel Approaches to Improve Immunotherapy. Biomedicines 2021;9:361. [PMID: 33807260 DOI: 10.3390/biomedicines9040361] [Reference Citation Analysis]
18 Ward AB, Keeton AB, Chen X, Mattox TE, Coley AB, Maxuitenko YY, Buchsbaum DJ, Randall TD, Zhou G, Piazza GA. Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS. MedComm (Beijing) 2020;1:121-8. [PMID: 33073260 DOI: 10.1002/mco2.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Hoch T, Schulz D, Eling N, Gómez JM, Levesque MP, Bodenmiller B. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy. Sci Immunol 2022;7:eabk1692. [PMID: 35363540 DOI: 10.1126/sciimmunol.abk1692] [Reference Citation Analysis]
20 Javitt A, Barnea E, Kramer MP, Wolf-Levy H, Levin Y, Admon A, Merbl Y. Pro-inflammatory Cytokines Alter the Immunopeptidome Landscape by Modulation of HLA-B Expression. Front Immunol 2019;10:141. [PMID: 30833945 DOI: 10.3389/fimmu.2019.00141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
21 Erin N. Role of sensory neurons, neuroimmune pathways, and transient receptor potential vanilloid 1 (TRPV1) channels in a murine model of breast cancer metastasis. Cancer Immunol Immunother 2020;69:307-14. [PMID: 31912230 DOI: 10.1007/s00262-019-02463-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
22 Linehan JL, Delamarre L. Teamwork by different T-cell types boosts tumour destruction by immunotherapy. Nature 2019;574:639-40. [PMID: 31659314 DOI: 10.1038/d41586-019-03106-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
23 Zhan X, Liu Y, Yu CY, Wang TF, Zhang J, Ni D, Huang K. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma. BMC Med Genomics 2020;13:190. [PMID: 33371886 DOI: 10.1186/s12920-020-00827-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Namdari H, Izad M, Rezaei F, Amirghofran Z. Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells. Int Immunopharmacol 2019;67:417-26. [PMID: 30586665 DOI: 10.1016/j.intimp.2018.12.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Le T, Su S, Kirshtein A, Shahriyari L. Data-Driven Mathematical Model of Osteosarcoma. Cancers (Basel) 2021;13:2367. [PMID: 34068946 DOI: 10.3390/cancers13102367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hoekstra ME, Bornes L, Dijkgraaf FE, Philips D, Pardieck IN, Toebes M, Thommen DS, van Rheenen J, Schumacher TNM. Long-distance modulation of bystander tumor cells by CD8+ T cell-secreted IFNγ. Nat Cancer 2020;1:291-301. [PMID: 32566933 DOI: 10.1038/s43018-020-0036-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
27 Li CM, Chen Z. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Front Cell Dev Biol 2021;9:664305. [PMID: 34235145 DOI: 10.3389/fcell.2021.664305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Allen DZ, Aljabban J, Silverman D, McDermott S, Wanner RA, Rohr M, Hadley D, Panahiazar M. Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis. PLoS One 2021;16:e0258187. [PMID: 34648530 DOI: 10.1371/journal.pone.0258187] [Reference Citation Analysis]
29 Chaurasiya S, Fong Y, Warner SG. Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges. Cancers (Basel) 2020;12:E1699. [PMID: 32604787 DOI: 10.3390/cancers12061699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
30 Wang T, Denman D, Bacot SM, Feldman GM. Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy. Biomedicines 2022;10:1181. [DOI: 10.3390/biomedicines10051181] [Reference Citation Analysis]
31 Kauffman MR, Nazemidashtarjandi S, Ghazanfari D, Allen AE, Reynolds NM, Faik A, Burdick MM, McCall KD, Goetz DJ. Evidence that knock down of GSK-3β in Chronic Myelogenous Leukemia cells augments IFN-γ-induced apoptosis. Leuk Res 2020;99:106464. [PMID: 33130330 DOI: 10.1016/j.leukres.2020.106464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Song Y, Tian S, Zhang P, Zhang N, Shen Y, Deng J. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia. Front Genet 2022;12:708699. [DOI: 10.3389/fgene.2021.708699] [Reference Citation Analysis]
33 Tu G, Peng W, Cai Q, Zhao Z, Peng X, He B, Zhang P, Shi S, Tao Y, Wang X. Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma. PeerJ 2021;9:e11687. [PMID: 34277151 DOI: 10.7717/peerj.11687] [Reference Citation Analysis]
34 Coste C, Gérard N, Dinh CP, Bruguière A, Rouger C, Leong ST, Awang K, Richomme P, Derbré S, Charreau B. Targeting MHC Regulation Using Polycyclic Polyprenylated Acylphloroglucinols Isolated from Garcinia bancana. Biomolecules 2020;10:E1266. [PMID: 32887413 DOI: 10.3390/biom10091266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
35 Owen KL, Brockwell NK, Parker BS. JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers (Basel) 2019;11:E2002. [PMID: 31842362 DOI: 10.3390/cancers11122002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 23.7] [Reference Citation Analysis]
36 Sood A, Lebel MÈ, Dong M, Fournier M, Vobecky SJ, Haddad É, Delisle JS, Mandl JN, Vrisekoop N, Melichar HJ. CD5 levels define functionally heterogeneous populations of naïve human CD4+ T cells. Eur J Immunol 2021;51:1365-76. [PMID: 33682083 DOI: 10.1002/eji.202048788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
37 Kacar M, Cortes-Acevedo P, Patel V, Carter C, Hughes P, McGann HP, Gkrania-Klotsas E, Baxendale HE, Barcenas-Morales G, Doffinger R, Savic S. Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection? J Clin Immunol 2021. [PMID: 34309742 DOI: 10.1007/s10875-021-01102-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Baydoun M, Moralès O, Frochot C, Ludovic C, Leroux B, Thecua E, Ziane L, Grabarz A, Kumar A, de Schutter C, Collinet P, Azais H, Mordon S, Delhem N. Photodynamic Therapy Using a New Folate Receptor-Targeted Photosensitizer on Peritoneal Ovarian Cancer Cells Induces the Release of Extracellular Vesicles with Immunoactivating Properties. J Clin Med 2020;9:E1185. [PMID: 32326210 DOI: 10.3390/jcm9041185] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 Baru A, Sharma S, Purakayastha BPD, Khan S, Mazumdar S, Gupta R, Kundu PK, Arora NM. AXTEX-4D: A Three-Dimensional Ex Vivo Platform for Preclinical Investigations of Immunotherapy Agents. Assay Drug Dev Technol 2021. [PMID: 34319797 DOI: 10.1089/adt.2021.031] [Reference Citation Analysis]
40 Winkler C, King M, Berthe J, Ferraioli D, Garuti A, Grillo F, Rodriguez-Canales J, Ferrando L, Chopin N, Ray-Coquard I, Delpuech O, Rinchai D, Bedognetti D, Ballestrero A, Leo E, Zoppoli G. SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer. JCI Insight 2021;6:e146098. [PMID: 34549724 DOI: 10.1172/jci.insight.146098] [Reference Citation Analysis]
41 Hoekstra ME, Vijver SV, Schumacher TN. Modulation of the tumor micro-environment by CD8+ T cell-derived cytokines. Curr Opin Immunol 2021;69:65-71. [PMID: 33862306 DOI: 10.1016/j.coi.2021.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Yu AI, Zhao L, Eaton KA, Ho S, Chen J, Poe S, Becker J, Gonzalez A, McKinstry D, Hasso M, Mendoza-Castrejon J, Whitfield J, Koumpouras C, Schloss PD, Martens EC, Chen GY. Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis. Cell Rep 2020;31:107471. [PMID: 32268087 DOI: 10.1016/j.celrep.2020.03.035] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 33.0] [Reference Citation Analysis]
43 Sivori S, Pende D, Quatrini L, Pietra G, Della Chiesa M, Vacca P, Tumino N, Moretta F, Mingari MC, Locatelli F, Moretta L. NK cells and ILCs in tumor immunotherapy. Mol Aspects Med 2021;80:100870. [PMID: 32800530 DOI: 10.1016/j.mam.2020.100870] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
44 Ke CH, Wang YS, Chiang HC, Wu HY, Liu WJ, Huang CC, Huang YC, Lin CS. Xenograft cancer vaccines prepared from immunodeficient mice increase tumor antigen diversity and host T cell efficiency against colorectal cancers. Cancer Lett 2022;526:66-75. [PMID: 34808284 DOI: 10.1016/j.canlet.2021.11.012] [Reference Citation Analysis]
45 Song X, Hu W, Yu H, Wang H, Zhao Y, Korngold R, Zhao Y. Existence of Circulating Mitochondria in Human and Animal Peripheral Blood. Int J Mol Sci 2020;21:E2122. [PMID: 32204530 DOI: 10.3390/ijms21062122] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
46 Nguyen A, Ramesh A, Kumar S, Nandi D, Brouillard A, Wells A, Pobezinsky L, Osborne B, Kulkarni AA. Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy. Sci Adv 2020;6:eabc2777. [PMID: 33008894 DOI: 10.1126/sciadv.abc2777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Wen J, Wang L, Ren J, Kranz E, Chen S, Wu D, Kanazawa T, Chen I, Lu Y, Kamata M. Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model. J Immunother Cancer 2021;9:e001524. [PMID: 33593826 DOI: 10.1136/jitc-2020-001524] [Reference Citation Analysis]
48 Wu J, Abraham SN. The Roles of T cells in Bladder Pathologies. Trends Immunol 2021;42:248-60. [PMID: 33536141 DOI: 10.1016/j.it.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Vitiello GAF, Ferreira WAS, Cordeiro de Lima VC, Medina TDS. Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment. Front Immunol 2021;12:782852. [PMID: 34925363 DOI: 10.3389/fimmu.2021.782852] [Reference Citation Analysis]
50 Abiri R, Abdul-Hamid H, Sytar O, Abiri R, Bezerra de Almeida E Jr, Sharma SK, Bulgakov VP, Arroo RRJ, Malik S. A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov. Molecules 2021;26:3868. [PMID: 34202844 DOI: 10.3390/molecules26133868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Chauhan SB, Faleiro R, Kumar R, Ng S, Singh B, Singh OP, Singh SS, Amante F, Rivera FL, Rai M, Chakravarty J, Sacks D, Nylen S, Sundar S, Engwerda C. Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential. J Infect Dis 2019;220:163-73. [PMID: 30796820 DOI: 10.1093/infdis/jiz074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
52 Wang R, Guo H, Tang X, Zhang T, Liu Y, Zhang C, Yu H, Li Y. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells. Inflammation 2021. [PMID: 34536158 DOI: 10.1007/s10753-021-01547-3] [Reference Citation Analysis]
53 Kittler JM, Sommer J, Fischer A, Britting S, Karg MM, Bock B, Atreya I, Heindl LM, Mackensen A, Bosch JJ. Characterization of CD4+ T cells primed and boosted by MHCII primary uveal melanoma cell-based vaccines. Oncotarget 2019;10:1812-28. [PMID: 30956760 DOI: 10.18632/oncotarget.26737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ranjan A, Kishore D, Ashar H, Neel T, Singh A, More S. Focused ultrasound ablation of a large canine oral tumor achieves efficient tumor remission: a case report. Int J Hyperthermia 2021;38:552-60. [PMID: 33784931 DOI: 10.1080/02656736.2021.1903582] [Reference Citation Analysis]
55 Martynova E, Davidyuk Y, Kabwe E, Garanina EE, Shakirova V, Pavelkina V, Uskova Y, Stott RJ, Foster TL, Markelova M, Goyal M, Gupta A, Bhola M, Kumar V, Baranwal M, Rizvanov AA, Khaiboullina SF. Cytokine, Chemokine, and Metalloprotease Activation in the Serum of Patients with Nephropathia Epidemica from the Republic of Tatarstan and the Republic of Mordovia, Russia. Pathogens 2021;10:527. [PMID: 33925451 DOI: 10.3390/pathogens10050527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Parker ME, Ciofani M. Regulation of γδ T Cell Effector Diversification in the Thymus. Front Immunol 2020;11:42. [PMID: 32038664 DOI: 10.3389/fimmu.2020.00042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
57 Mirando AC, Patil A, Rafie CI, Christmas BJ, Pandey NB, Stearns V, Jaffee EM, Roussos Torres ET, Popel AS. Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide. Oncoimmunology 2020;9:1760685. [PMID: 32923118 DOI: 10.1080/2162402X.2020.1760685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Vidovic D, Giacomantonio C. Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma. Cancers (Basel) 2020;12:E1321. [PMID: 32455916 DOI: 10.3390/cancers12051321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Fenton SE, Saleiro D, Platanias LC. Type I and II Interferons in the Anti-Tumor Immune Response. Cancers (Basel) 2021;13:1037. [PMID: 33801234 DOI: 10.3390/cancers13051037] [Reference Citation Analysis]
60 Gerber HP, Sibener LV, Lee LJ, Gee MH. Identification of Antigenic Targets. Trends Cancer 2020;6:299-318. [PMID: 32209445 DOI: 10.1016/j.trecan.2020.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Lin Y, Lu R, Hou J, Zhou GG, Fu W. IFNgamma-inducible CXCL10/CXCR3 axis alters the sensitivity of HEp-2 cells to ionizing radiation. Exp Cell Res 2021;398:112382. [PMID: 33253709 DOI: 10.1016/j.yexcr.2020.112382] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Smith JA. STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation? Front Immunol 2020;11:611347. [PMID: 33552072 DOI: 10.3389/fimmu.2020.611347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Choi JU, Maharjan R, Pangeni R, Jha SK, Lee NK, Kweon S, Lee HK, Chang KY, Choi YK, Park JW, Byun Y. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion. J Control Release 2020;322:13-30. [PMID: 32169534 DOI: 10.1016/j.jconrel.2020.03.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
64 Shi LZ, Bonner JA. Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis. Int J Mol Sci 2021;22:12295. [PMID: 34830176 DOI: 10.3390/ijms222212295] [Reference Citation Analysis]
65 Temizoz B, Ishii KJ. Type I and II interferons toward ideal vaccine and immunotherapy. Expert Rev Vaccines 2021;20:527-44. [PMID: 33993812 DOI: 10.1080/14760584.2021.1927724] [Reference Citation Analysis]
66 Park MJ, Jang EH, Kim AY, Kim H, Kim HS, Byun S, Yu HY, Jeon HJ. Comparison of Peripheral Biomarkers and Reduction of Stress Response in Patients With Major Depressive Disorders vs. Panic Disorder. Front Psychiatry 2022;13:842963. [DOI: 10.3389/fpsyt.2022.842963] [Reference Citation Analysis]
67 Lee H, Da Silva IP, Palendira U, Scolyer RA, Long GV, Wilmott JS. Targeting NK Cells to Enhance Melanoma Response to Immunotherapies. Cancers (Basel) 2021;13:1363. [PMID: 33802954 DOI: 10.3390/cancers13061363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ahluwalia P, Ahluwalia M, Mondal AK, Sahajpal NS, Kota V, Rojiani MV, Kolhe R. Natural Killer Cells and Dendritic Cells: Expanding Clinical Relevance in the Non-Small Cell Lung Cancer (NSCLC) Tumor Microenvironment. Cancers (Basel) 2021;13:4037. [PMID: 34439191 DOI: 10.3390/cancers13164037] [Reference Citation Analysis]
69 Abdelmoneim AH, Mustafa MI, Abdelmageed MI, Murshed NS, Dawoud ED, Ahmed EM, Kamal Eldein RM, Elfadol NM, Sati AOM, Makhawi AM. Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target. Immunol Med 2021;44:35-52. [PMID: 32692610 DOI: 10.1080/25785826.2020.1794165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
70 Esteves AM, Papaevangelou E, Dasgupta P, Galustian C. Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer. Front Oncol 2021;11:621550. [PMID: 33777767 DOI: 10.3389/fonc.2021.621550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sterle HA, Nicoud MB, Massari NA, Táquez Delgado MA, Herrero Ducloux MV, Cremaschi GA, Medina VA. Immunomodulatory role of histamine H4 receptor in breast cancer. Br J Cancer 2019;120:128-38. [PMID: 29988113 DOI: 10.1038/s41416-018-0173-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
72 Bte Syed Sulaiman N, Kuick CH, Chang KTE, Wan KR, Looi WS, Low DCY, Seow WT, Low SYY. Cytokines in Pediatric Pilocytic Astrocytomas: A Clinico-Pathological Study. NeuroSci 2021;2:95-108. [DOI: 10.3390/neurosci2010006] [Reference Citation Analysis]
73 Ye ZH, Jiang XM, Huang MY, Xu YL, Chen YC, Yuan LW, Huang CY, Yu WB, Chen X, Lu JJ. Regulation of CD47 expression by interferon-gamma in cancer cells. Transl Oncol 2021;14:101162. [PMID: 34171557 DOI: 10.1016/j.tranon.2021.101162] [Reference Citation Analysis]
74 Sabbatino F, Liguori L, Polcaro G, Salvato I, Caramori G, Salzano FA, Casolaro V, Stellato C, Col JD, Pepe S. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients. Int J Mol Sci 2020;21:E7295. [PMID: 33023239 DOI: 10.3390/ijms21197295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
75 Morales-Lange B, Nombela I, Ortega-Villaizán MDM, Imarai M, Schmitt P, Mercado L. Induction of foxp3 during the Crosstalk between Antigen Presenting Like-Cells MHCII+CD83+ and Splenocytes CD4+IgM- in Rainbow Trout. Biology (Basel) 2021;10:324. [PMID: 33924548 DOI: 10.3390/biology10040324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Luna-Yolba R, Marmoiton J, Gigo V, Marechal X, Boet E, Sahal A, Alet N, Abramovich I, Gottlieb E, Visentin V, Paillasse MR, Sarry JE. Disrupting Mitochondrial Electron Transfer Chain Complex I Decreases Immune Checkpoints in Murine and Human Acute Myeloid Leukemic Cells. Cancers (Basel) 2021;13:3499. [PMID: 34298712 DOI: 10.3390/cancers13143499] [Reference Citation Analysis]
77 Dolejsi T, Delgobo M, Schuetz T, Tortola L, Heinze KG, Hofmann U, Frantz S, Bauer A, Ruschitzka F, Penninger JM, Campos Ramos G, Haubner BJ. Adult T-cells impair neonatal cardiac regeneration. Eur Heart J 2022:ehac188. [PMID: 35417553 DOI: 10.1093/eurheartj/ehac153] [Reference Citation Analysis]
78 Qin SS, Han BJ, Williams A, Jackson KM, Jewell R, Chacon AC, Lord EM, Linehan DC, Kim M, Reuben A, Gerber SA, Prieto PA. Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model. Cancers (Basel) 2021;13:2293. [PMID: 34064795 DOI: 10.3390/cancers13102293] [Reference Citation Analysis]
79 Wang Z, Chen Z, Zhao H, Lin H, Wang J, Wang N, Li X, Ding D. ISPRF: a machine learning model to predict the immune subtype of kidney cancer samples by four genes. Transl Androl Urol 2021;10:3773-86. [PMID: 34804821 DOI: 10.21037/tau-21-650] [Reference Citation Analysis]
80 Park S, Oh JH, Park DJ, Zhang H, Noh M, Kim Y, Kim YS, Kim H, Kim YM, Ha SJ, Kwon YG. CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells. Front Immunol 2020;11:620166. [PMID: 33584714 DOI: 10.3389/fimmu.2020.620166] [Reference Citation Analysis]
81 Schmidt M, Heimes AS. Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical Practice. Cancers (Basel) 2021;13:4883. [PMID: 34638367 DOI: 10.3390/cancers13194883] [Reference Citation Analysis]
82 Prigge AD, Ma R, Coates BM, Singer BD, Ridge KM. Age-Dependent Differences in T-Cell Responses to Influenza A Virus. Am J Respir Cell Mol Biol 2020;63:415-23. [PMID: 32609537 DOI: 10.1165/rcmb.2020-0169TR] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Vanderwall AG, Milligan ED. Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management. Front Immunol 2019;10:3009. [PMID: 31921220 DOI: 10.3389/fimmu.2019.03009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
84 Zaidi MR. The Interferon-Gamma Paradox in Cancer. J Interferon Cytokine Res 2019;39:30-8. [PMID: 30388040 DOI: 10.1089/jir.2018.0087] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
85 Ramesh P, Shivde R, Jaishankar D, Saleiro D, Le Poole IC. A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics. Cancers (Basel) 2021;13:821. [PMID: 33669271 DOI: 10.3390/cancers13040821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Karapetyan L, Luke JJ, Davar D. Toll-Like Receptor 9 Agonists in Cancer. Onco Targets Ther 2020;13:10039-60. [PMID: 33116588 DOI: 10.2147/OTT.S247050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
87 Friedrich M, Jasinski-Bergner S, Lazaridou MF, Subbarayan K, Massa C, Tretbar S, Mueller A, Handke D, Biehl K, Bukur J, Donia M, Mandelboim O, Seliger B. Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunol Immunother 2019;68:1689-700. [PMID: 31375885 DOI: 10.1007/s00262-019-02373-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 11.7] [Reference Citation Analysis]
88 Ishikura N, Sugimoto M, Yorozu K, Kurasawa M, Kondoh O. Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors. Oncol Rep 2022;47:36. [PMID: 34958105 DOI: 10.3892/or.2021.8247] [Reference Citation Analysis]
89 Qusa MH, Abdelwahed KS, Meyer SA, El Sayed KA. Olive Oil Lignan (+)-Acetoxypinoresinol Peripheral Motor and Neuronal Protection against the Tremorgenic Mycotoxin Penitrem A Toxicity via STAT1 Pathway. ACS Chem Neurosci 2020;11:3575-89. [PMID: 32991800 DOI: 10.1021/acschemneuro.0c00458] [Reference Citation Analysis]
90 Xu L, Pelosof L, Wang R, McFarland HI, Wu WW, Phue JN, Lee CT, Shen RF, Juhl H, Wu LH, Alterovitz WL, Petricon E, Rosenberg AS. NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes. Front Immunol 2020;11:224. [PMID: 32265897 DOI: 10.3389/fimmu.2020.00224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
91 Gu H, Zhang Y, Zeng W, Xia Y. Participation of interferons in psoriatic inflammation. Cytokine Growth Factor Rev 2021:S1359-6101(21)00093-9. [PMID: 34953718 DOI: 10.1016/j.cytogfr.2021.12.002] [Reference Citation Analysis]
92 Bucciol G, Moens L, Bosch B, Bossuyt X, Casanova JL, Puel A, Meyts I. Lessons learned from the study of human inborn errors of innate immunity. J Allergy Clin Immunol 2019;143:507-27. [PMID: 30075154 DOI: 10.1016/j.jaci.2018.07.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
93 Puchert M, Obst J, Koch C, Zieger K, Engele J. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Cytokine 2020;125:154809. [PMID: 31437604 DOI: 10.1016/j.cyto.2019.154809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
94 Jones EL, Laidlaw SM, Dustin LB. TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease. Front Immunol 2021;12:738473. [PMID: 34552597 DOI: 10.3389/fimmu.2021.738473] [Reference Citation Analysis]
95 Verdon DJ, Mulazzani M, Jenkins MR. Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion. Int J Mol Sci 2020;21:E7357. [PMID: 33027962 DOI: 10.3390/ijms21197357] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
96 Oxley KL, Hanson BM, Zani AN, Bishop GA. Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine. Cancer Immunol Immunother 2021. [PMID: 33765210 DOI: 10.1007/s00262-021-02914-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Al-Musawi S, Albukhaty S, Al-Karagoly H, Almalki F. Design and Synthesis of Multi-Functional Superparamagnetic Core-Gold Shell Coated with Chitosan and Folate Nanoparticles for Targeted Antitumor Therapy. Nanomaterials (Basel) 2020;11:E32. [PMID: 33374415 DOI: 10.3390/nano11010032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
98 Stakheyeva M, Patysheva M, Kaigorodova E, Zavyalova M, Tarabanovskaya N, Choynzonov E, Cherdyntseva N. Tumor Properties Mediate the Relationship Between Peripheral Blood Monocytes and Tumor-Associated Macrophages in Breast Cancer. Cancer Invest 2021;:1-20. [PMID: 34882039 DOI: 10.1080/07357907.2021.2016803] [Reference Citation Analysis]
99 Sjöbom U, Christenson K, Hellström A, Nilsson AK. Inflammatory Markers in Suction Blister Fluid: A Comparative Study Between Interstitial Fluid and Plasma. Front Immunol 2020;11:597632. [PMID: 33224151 DOI: 10.3389/fimmu.2020.597632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
100 Wang H, Yung MMH, Ngan HYS, Chan KKL, Chan DW. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression. Int J Mol Sci 2021;22:6560. [PMID: 34207286 DOI: 10.3390/ijms22126560] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Kumbhari A, Rose D, Lee PP, Kim PS. A minimal model of T cell avidity may identify subtherapeutic vaccine schedules. Math Biosci 2021;334:108556. [PMID: 33539903 DOI: 10.1016/j.mbs.2021.108556] [Reference Citation Analysis]
102 Saleiro D, Platanias LC. Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints. Semin Immunol 2019;43:101299. [PMID: 31771762 DOI: 10.1016/j.smim.2019.101299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
103 Gnodi E, Mancuso C, Elli L, Ballarini E, Meneveri R, Beaulieu JF, Barisani D. Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa. Int J Mol Sci 2021;22:1289. [PMID: 33525473 DOI: 10.3390/ijms22031289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Gupta A, Rosato AJ, Cui F. Vaccine candidate designed against carcinoembryonic antigen-related cell adhesion molecules using immunoinformatics tools. J Biomol Struct Dyn 2021;39:6084-98. [PMID: 32720576 DOI: 10.1080/07391102.2020.1797539] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Marín-Jiménez JA, Capasso A, Lewis MS, Bagby SM, Hartman SJ, Shulman J, Navarro NM, Yu H, Rivard CJ, Wang X, Barkow JC, Geng D, Kar A, Yingst A, Tufa DM, Dolan JT, Blatchford PJ, Freed BM, Torres RM, Davila E, Slansky JE, Pelanda R, Eckhardt SG, Messersmith WA, Diamond JR, Lieu CH, Verneris MR, Wang JH, Kiseljak-Vassiliades K, Pitts TM, Lang J. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes. Front Immunol 2021;12:607282. [PMID: 33854497 DOI: 10.3389/fimmu.2021.607282] [Reference Citation Analysis]
106 Lampert EJ, Zimmer A, Padget M, Cimino-Mathews A, Nair JR, Liu Y, Swisher EM, Hodge JW, Nixon AB, Nichols E, Bagheri MH, Levy E, Radke MR, Lipkowitz S, Annunziata CM, Taube JM, Steinberg SM, Lee JM. Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clin Cancer Res 2020;26:4268-79. [PMID: 32398324 DOI: 10.1158/1078-0432.CCR-20-0056] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 16.5] [Reference Citation Analysis]
107 Lofiego MF, Cannito S, Fazio C, Piazzini F, Cutaia O, Solmonese L, Marzani F, Chiarucci C, Di Giacomo AM, Calabrò L, Coral S, Maio M, Covre A, On Behalf Of The EPigenetic Immune-Oncology Consortium Airc Epica Investigators. Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. Epigenomes 2021;5:27. [PMID: 34968251 DOI: 10.3390/epigenomes5040027] [Reference Citation Analysis]
108 Savsani K, Jabbour G, Dakshanamurthy S. A New Epitope Selection Method: Application to Design a Multi-Valent Epitope Vaccine Targeting HRAS Oncogene in Squamous Cell Carcinoma. Vaccines (Basel) 2021;10:63. [PMID: 35062725 DOI: 10.3390/vaccines10010063] [Reference Citation Analysis]
109 Galiano-Landeira J, Torra A, Vila M, Bové J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease. Brain 2020;143:3717-33. [PMID: 33118032 DOI: 10.1093/brain/awaa269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
110 Li Y, Ji H, Gao X. A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma. Front Med 2022;9:846847. [DOI: 10.3389/fmed.2022.846847] [Reference Citation Analysis]
111 Chen AY, Wolchok JD, Bass AR. TNF in the era of immune checkpoint inhibitors: friend or foe? Nat Rev Rheumatol 2021;17:213-23. [PMID: 33686279 DOI: 10.1038/s41584-021-00584-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
112 Jung I, Jung D, Zha Z, Jeong J, Noh S, Shin J, Park JK, Kim KS, Jeong Y, Hur J, Baek MC, Diaz-Aguilar S, Aguilar E, Friedlander M, Bucher F, Yea K. Interferon-γ inhibits retinal neovascularization in a mouse model of ischemic retinopathy. Cytokine 2021;143:155542. [PMID: 33926775 DOI: 10.1016/j.cyto.2021.155542] [Reference Citation Analysis]
113 Naqvi RA, Datta M, Khan SH, Naqvi AR. Regulatory roles of MicroRNA in shaping T cell function, differentiation and polarization. Semin Cell Dev Biol 2021:S1084-9521(21)00207-X. [PMID: 34446356 DOI: 10.1016/j.semcdb.2021.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Cautivo KM, Matatia PR, Lizama CO, Mroz NM, Dahlgren MW, Yu X, Sbierski-Kind J, Taruselli MT, Brooks JF, Wade-Vallance A, Caryotakis SE, Chang AA, Liang HE, Zikherman J, Locksley RM, Molofsky AB. Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation. Immunity 2022;55:254-271.e7. [PMID: 35139352 DOI: 10.1016/j.immuni.2021.12.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Tumino N, Vacca P, Quatrini L, Munari E, Moretta F, Pelosi A, Mariotti FR, Moretta L. Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? Front Immunol 2019;10:3140. [PMID: 32063901 DOI: 10.3389/fimmu.2019.03140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
116 Yang Z, Gao A, Shi W, Wang J, Zhang X, Xu Z, Xu T, Zheng Y, Sun Y, Yang F. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression. Onco Targets Ther 2021;14:4239-54. [PMID: 34321889 DOI: 10.2147/OTT.S290348] [Reference Citation Analysis]
117 Hu Y, Liu T, Li J, Mai F, Li J, Chen Y, Jing Y, Dong X, Lin L, He J, Xu Y, Shan C, Hao J, Yin Z, Chen T, Wu Y. Selenium nanoparticles as new strategy to potentiate γδ T cell anti-tumor cytotoxicity through upregulation of tubulin-α acetylation. Biomaterials 2019;222:119397. [PMID: 31442884 DOI: 10.1016/j.biomaterials.2019.119397] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
118 Yamashita N, Long M, Fushimi A, Yamamoto M, Hata T, Hagiwara M, Bhattacharya A, Hu Q, Wong KK, Liu S, Kufe D. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer. J Immunother Cancer 2021;9:e002115. [PMID: 33495298 DOI: 10.1136/jitc-2020-002115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Xu D, Song X, Zhou J, Ouyang X, Li J, Deng D. Virus-like hollow mesoporous silica nanoparticles for cancer combination therapy. Colloids and Surfaces B: Biointerfaces 2021;197:111452. [DOI: 10.1016/j.colsurfb.2020.111452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
120 Mariottoni P, Jiang SW, Prestwood CA, Jain V, Suwanpradid J, Whitley MJ, Coates M, Brown DA, Erdmann D, Corcoran DL, Gregory SG, Jaleel T, Zhang JY, Harris-Tryon TA, MacLeod AS. Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With M1 Macrophage Polarization in Hidradenitis Suppurativa. Front Med (Lausanne) 2021;8:665873. [PMID: 34504848 DOI: 10.3389/fmed.2021.665873] [Reference Citation Analysis]
121 Santos HM, Chen CC, Tsai CY, Hsish YC, Chung FC, Tyan YC, Tayo LL, Chuang KP. Influence of pigeon interferon alpha (PiIFN-α) on pigeon circovirus (PiCV) replication and cytokine expression in Columba livia. Vet Microbiol 2020;242:108591. [PMID: 32122595 DOI: 10.1016/j.vetmic.2020.108591] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
122 Ji H, Ba Y, Ma S, Hou K, Mi S, Gao X, Jin J, Gong Q, Liu T, Wang F, Liu Z, Li S, Du J, Hu S. Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy. Front Immunol 2021;12:729359. [PMID: 34566988 DOI: 10.3389/fimmu.2021.729359] [Reference Citation Analysis]
123 Poillet-Perez L, Sharp DW, Yang Y, Laddha SV, Ibrahim M, Bommareddy PK, Sherrie Hu Z, Vieth J, Haas M, Bosenberg MW, Rabinowitz JD, Cao J, Guan JL, Ganesan S, Chan CS, Mehnert JM, Lattime EC, White E. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response. Nat Cancer 2020;1:923-34. [PMID: 34476408 DOI: 10.1038/s43018-020-00110-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
124 Uricoli B, Birnbaum LA, Do P, Kelvin JM, Jain J, Costanza E, Chyong A, Porter CC, Rafiq S, Dreaden EC. Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy. Adv Healthc Mater 2021;10:e2002214. [PMID: 33690997 DOI: 10.1002/adhm.202002214] [Reference Citation Analysis]
125 Cui C, Xu C, Yang W, Chi Z, Sheng X, Si L, Xie Y, Yu J, Wang S, Yu R, Guo J, Kong Y. Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma. NPJ Genom Med 2021;6:7. [PMID: 33542239 DOI: 10.1038/s41525-021-00169-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
126 Salomon N, Selmi A, Grunwitz C, Kong A, Stanganello E, Neumaier J, Petschenka J, Diken M, Kreiter S, Türeci Ö, Sahin U, Vascotto F. Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer. Cancer Immunol Immunother 2021. [PMID: 34971406 DOI: 10.1007/s00262-021-03134-9] [Reference Citation Analysis]
127 Chernosky NM, Tamagno I. The Role of the Innate Immune System in Cancer Dormancy and Relapse. Cancers (Basel) 2021;13:5621. [PMID: 34830776 DOI: 10.3390/cancers13225621] [Reference Citation Analysis]
128 Bozic T, Sersa G, Kranjc Brezar S, Cemazar M, Markelc B. Gene electrotransfer of proinflammatory chemokines CCL5 and CCL17 as a novel approach of modifying cytokine expression profile in the tumor microenvironment. Bioelectrochemistry 2021;140:107795. [PMID: 33789177 DOI: 10.1016/j.bioelechem.2021.107795] [Reference Citation Analysis]
129 Rezaeean H, Kaydani GA, Saki N, Razmjoo S, Labibzadeh M, Yaghooti H. The IFN-Ɣ + 874 A/T polymorphism is associated with malignant breast cancer in a population from the southwest of Iran. BMC Res Notes 2021;14:147. [PMID: 33879226 DOI: 10.1186/s13104-021-05543-6] [Reference Citation Analysis]
130 Liang F, Rezapour A, Falk P, Angenete E, Yrlid U. Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T Cells. Cancers (Basel) 2021;13:2428. [PMID: 34067849 DOI: 10.3390/cancers13102428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Cetintas VB, Batada NN. Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? J Transl Med 2020;18:45. [PMID: 32000794 DOI: 10.1186/s12967-020-02219-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
132 Wang Y, Zhao C, Liu Y, Wang C, Jiang H, Hu Y, Wu J. Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis. Mol Pharm 2022. [PMID: 35436123 DOI: 10.1021/acs.molpharmaceut.2c00073] [Reference Citation Analysis]
133 McKernan P, Virani NA, Faria GNF, Karch CG, Prada Silvy R, Resasco DE, Thompson LF, Harrison RG. Targeted Single-Walled Carbon Nanotubes for Photothermal Therapy Combined with Immune Checkpoint Inhibition for the Treatment of Metastatic Breast Cancer. Nanoscale Res Lett 2021;16:9. [PMID: 33411055 DOI: 10.1186/s11671-020-03459-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Vafa O, Trinklein ND. Perspective: Designing T-Cell Engagers With Better Therapeutic Windows. Front Oncol 2020;10:446. [PMID: 32351885 DOI: 10.3389/fonc.2020.00446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
135 AbuSamra DB, Panjwani N, Argüeso P. Induction of CXCL10-Mediated Cell Migration by Different Types of Galectins. Cells 2021;10:274. [PMID: 33573183 DOI: 10.3390/cells10020274] [Reference Citation Analysis]
136 Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol 2021;18:85-100. [PMID: 32934330 DOI: 10.1038/s41571-020-0426-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 28.5] [Reference Citation Analysis]
137 Zhang L, Xu X, Su X. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application. Mol Cancer 2020;19:48. [PMID: 32122338 DOI: 10.1186/s12943-020-01154-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
138 Zhao YC, Tang D, Yang S, Liu H, Luo S, Stinchcombe TE, Glass C, Su L, Shen S, Christiani DC, Wei Q. Novel Variants of ELP2 and PIAS1 in the Interferon Gamma Signaling Pathway Are Associated with Non-Small Cell Lung Cancer Survival. Cancer Epidemiol Biomarkers Prev 2020;29:1679-88. [PMID: 32493705 DOI: 10.1158/1055-9965.EPI-19-1450] [Reference Citation Analysis]
139 Smazynski J, Hamilton PT, Thornton S, Milne K, Wouters MCA, Webb JR, Nelson BH. The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers. Gynecol Oncol 2020;158:167-77. [PMID: 32446718 DOI: 10.1016/j.ygyno.2020.04.689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
140 Aboalsoud A, El-Ghaiesh SH, Abd Elmonem FF, Salem ML, Abdel Rahman MN. The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response. Int Immunopharmacol 2020;78:106068. [PMID: 31835085 DOI: 10.1016/j.intimp.2019.106068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
141 Abolfathi H, Sheikhpour M, Shahraeini SS, Khatami S, Nojoumi SA. Studies in lung cancer cytokine proteomics: a review. Expert Rev Proteomics 2021;18:49-64. [PMID: 33612047 DOI: 10.1080/14789450.2021.1892491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
142 Felsenstein M, Blank A, Bungert AD, Mueller A, Ghori A, Kremenetskaia I, Rung O, Broggini T, Turkowski K, Scherschinski L, Raggatz J, Vajkoczy P, Brandenburg S. CCR2 of Tumor Microenvironmental Cells Is a Relevant Modulator of Glioma Biology. Cancers (Basel) 2020;12:E1882. [PMID: 32668709 DOI: 10.3390/cancers12071882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
143 Glassman CR, Su L, Majri-Morrison SS, Winkelmann H, Mo F, Li P, Pérez-Cruz M, Ho PP, Koliesnik I, Nagy N, Hnizdilova T, Picton LK, Kovar M, Bollyky P, Steinman L, Meyer E, Piehler J, Leonard WJ, Garcia KC. Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist. Elife 2021;10:e65777. [PMID: 34003116 DOI: 10.7554/eLife.65777] [Reference Citation Analysis]
144 Stifter K, Krieger J, Ruths L, Gout J, Mulaw M, Lechel A, Kleger A, Seufferlein T, Wagner M, Schirmbeck R. IFN-γ treatment protocol for MHC-Ilo/PD-L1+ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential. J Immunother Cancer 2020;8:e000692. [PMID: 32868392 DOI: 10.1136/jitc-2020-000692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Paillet J, Plantureux C, Lévesque S, Le Naour J, Stoll G, Sauvat A, Caudana P, Tosello Boari J, Bloy N, Lachkar S, Martins I, Opolon P, Checcoli A, Delaune A, Robil N, de la Grange P, Hamroune J, Letourneur F, Autret G, Leung PSC, Gershwin ME, Zhu JS, Kurth MJ, Lekbaby B, Augustin J, Kim Y, Gujar S, Coulouarn C, Fouassier L, Zitvogel L, Piaggio E, Housset C, Soussan P, Maiuri MC, Kroemer G, Pol JG. Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma. J Exp Med 2021;218:e20200853. [PMID: 34495298 DOI: 10.1084/jem.20200853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Schroeder JH, Roberts LB, Meissl K, Lo JW, Hromadová D, Hayes K, Zabinski T, Read E, Moreira Heliodoro C, Reis R, Howard JK, Grencis RK, Neves JF, Strobl B, Lord GM. Sustained Post-Developmental T-Bet Expression Is Critical for the Maintenance of Type One Innate Lymphoid Cells In Vivo. Front Immunol 2021;12:760198. [PMID: 34795671 DOI: 10.3389/fimmu.2021.760198] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Giunta EF, Barra G, De Falco V, Argenziano G, Napolitano S, Vitale P, Zanaletti N, Terminiello M, Martinelli E, Morgillo F, Ciardiello D, De Palma R, Ciardiello F, Troiani T. Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients. Sci Rep 2020;10:17626. [PMID: 33077770 DOI: 10.1038/s41598-020-72711-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Chong C, Müller M, Pak H, Harnett D, Huber F, Grun D, Leleu M, Auger A, Arnaud M, Stevenson BJ, Michaux J, Bilic I, Hirsekorn A, Calviello L, Simó-Riudalbas L, Planet E, Lubiński J, Bryśkiewicz M, Wiznerowicz M, Xenarios I, Zhang L, Trono D, Harari A, Ohler U, Coukos G, Bassani-Sternberg M. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat Commun 2020;11:1293. [PMID: 32157095 DOI: 10.1038/s41467-020-14968-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 21.5] [Reference Citation Analysis]
149 Po JW, Ma Y, Balakrishnar B, Brungs D, Azimi F, Cooper A, Saricilar E, Murthy V, de Souza P, Becker TM. PD-L1 Detection on Circulating Melanoma Cells. Methods Mol Biol 2021;2265:223-33. [PMID: 33704718 DOI: 10.1007/978-1-0716-1205-7_17] [Reference Citation Analysis]
150 Choudhury SM, Ma X, Dang W, Li Y, Zheng H. Recent Development of Ruminant Vaccine Against Viral Diseases. Front Vet Sci 2021;8:697194. [PMID: 34805327 DOI: 10.3389/fvets.2021.697194] [Reference Citation Analysis]
151 Nabizadeh JA, Manthey HD, Panagides N, Steyn FJ, Lee JD, Li XX, Akhir FNM, Chen W, Boyle GM, Taylor SM, Woodruff TM, Rolfe BE. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma. FASEB J 2019;33:11060-71. [PMID: 31298935 DOI: 10.1096/fj.201800980RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
152 Gao L, Dong Y, Lin R, Meng Y, Wu F, Jia L. The imbalance of Treg/Th17 cells induced by perinatal bisphenol A exposure is associated with activation of the PI3K/Akt/mTOR signaling pathway in male offspring mice. Food and Chemical Toxicology 2020;137:111177. [DOI: 10.1016/j.fct.2020.111177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
153 Schratter G, Scheruebel S, Langthaler S, Ester K, Pelzmann B, Ghaffari-Tabrizi-Wizsy N, Rezania S, Gorischek A, Platzer D, Zorn-Pauly K, Ahammer H, Prokesch A, Stanzer S, Devaney TTJ, Schmidt K, Jahn SW, Prassl R, Bauernhofer T, Schreibmayer W. GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A. Sci Rep 2019;9:19277. [PMID: 31848385 DOI: 10.1038/s41598-019-55683-w] [Reference Citation Analysis]
154 Tian M, Wang T, Wang P. Development and Clinical Validation of a Seven-Gene Prognostic Signature Based on Multiple Machine Learning Algorithms in Kidney Cancer. Cell Transplant 2021;30:963689720969176. [PMID: 33626918 DOI: 10.1177/0963689720969176] [Reference Citation Analysis]
155 Shey RA, Ghogomu SM, Shintouo CM, Nkemngo FN, Nebangwa DN, Esoh K, Yaah NE, Manka'aFri M, Nguve JE, Ngwese RA, Njume FN, Bertha FA, Ayong L, Njemini R, Vanhamme L, Souopgui J. Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate against Onchocerciasis and Related Filarial Diseases. Pathogens 2021;10:99. [PMID: 33494344 DOI: 10.3390/pathogens10020099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Dhiman DK, Sanyal SN, Vaish V. Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling. Cell Signal 2020;76:109803. [PMID: 33022360 DOI: 10.1016/j.cellsig.2020.109803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Stern PL, Dalianis T. Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors. Viruses 2021;13:1234. [PMID: 34202255 DOI: 10.3390/v13071234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Xia M, Luo TY, Shi Y, Wang G, Tsui H, Harari D, Spaner DE. Effect of Ibrutinib on the IFN Response of Chronic Lymphocytic Leukemia Cells. J Immunol 2020;205:2629-39. [PMID: 33067379 DOI: 10.4049/jimmunol.2000478] [Reference Citation Analysis]
159 Klatt F, Leitner A, Kim IV, Ho-Xuan H, Schneider EV, Langhammer F, Weinmann R, Müller MR, Huber R, Meister G, Kuhn CD. A precisely positioned MED12 activation helix stimulates CDK8 kinase activity. Proc Natl Acad Sci U S A 2020;117:2894-905. [PMID: 31988137 DOI: 10.1073/pnas.1917635117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
160 de Miguel D, Ramirez-Labrada A, Uranga I, Hidalgo S, Santiago L, Galvez EM, Arias M, Pardo J. Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison. FEBS J 2021. [PMID: 34174027 DOI: 10.1111/febs.16093] [Reference Citation Analysis]
161 Jin QY, Li YS, Qiao XH, Yang JW, Guo XL. Targeting galectins in T cell-based immunotherapy within tumor microenvironment. Life Sci 2021;277:119426. [PMID: 33785342 DOI: 10.1016/j.lfs.2021.119426] [Reference Citation Analysis]
162 Pan S, Li T, Tan Y, Xu H. Selenium-containing nanoparticles synergistically enhance Pemetrexed&NK cell-based chemoimmunotherapy. Biomaterials 2022;280:121321. [PMID: 34922271 DOI: 10.1016/j.biomaterials.2021.121321] [Reference Citation Analysis]
163 Lu W, Wu Y, Huang S, Zhang D. A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma. Front Genet 2021;12:755486. [PMID: 34745224 DOI: 10.3389/fgene.2021.755486] [Reference Citation Analysis]
164 Angelicola S, Ruzzi F, Landuzzi L, Scalambra L, Gelsomino F, Ardizzoni A, Nanni P, Lollini PL, Palladini A. IFN-γ and CD38 in Hyperprogressive Cancer Development. Cancers (Basel) 2021;13:309. [PMID: 33467713 DOI: 10.3390/cancers13020309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 du Plessis M, Fourie C, Riedemann J, de Villiers WJS, Engelbrecht AM. Cancer and Covid-19: Collectively catastrophic. Cytokine Growth Factor Rev 2021:S1359-6101(21)00077-0. [PMID: 34794863 DOI: 10.1016/j.cytogfr.2021.10.005] [Reference Citation Analysis]
166 Kyriakides TR, Kim HJ, Zheng C, Harkins L, Tao W, Deschenes E. Foreign body response to synthetic polymer biomaterials and the role of adaptive immunity. Biomed Mater 2022;17. [PMID: 35168213 DOI: 10.1088/1748-605X/ac5574] [Reference Citation Analysis]
167 Muoio F, Panella S, Harder Y, Tallone T. Induction of the CD24 Surface Antigen in Primary Undifferentiated Human Adipose Progenitor Cells by the Hedgehog Signaling Pathway. Biologics 2021;1:129-53. [DOI: 10.3390/biologics1020008] [Reference Citation Analysis]
168 Sivakumar R, Chan M, Shin JS, Nishida-Aoki N, Kenerson HL, Elemento O, Beltran H, Yeung R, Gujral TS. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery. Oncoimmunology 2019;8:e1670019. [PMID: 31741771 DOI: 10.1080/2162402X.2019.1670019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
169 Otegbeye EE, Mitchem JB, Park H, Chaudhuri AA, Kim H, Mutch MG, Ciorba MA. Immunity, immunotherapy, and rectal cancer: A clinical and translational science review. Transl Res 2021;231:124-38. [PMID: 33307273 DOI: 10.1016/j.trsl.2020.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
170 Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, Withers HG, Hu Q, Liu T, Liu S, Wong KK, Long MD, Kufe D. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. OncoImmunology 2022;11:2029298. [DOI: 10.1080/2162402x.2022.2029298] [Reference Citation Analysis]
171 Lim JU, Yoon HK. Potential predictive value of change in inflammatory cytokines levels subsequent to initiation of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer. Cytokine 2021;138:155363. [PMID: 33264749 DOI: 10.1016/j.cyto.2020.155363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
172 Kong SK, Kim BS, Lim H, Kim HJ, Kim YS. Dissection of PD-L1 promoter reveals differential transcriptional regulation of PD-L1 in VHL mutant clear cell renal cell carcinoma. Lab Invest 2021. [PMID: 34789838 DOI: 10.1038/s41374-021-00703-5] [Reference Citation Analysis]
173 Ye Y, Xu C, Chen F, Liu Q, Cheng N. Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review. Front Immunol 2021;12:771201. [PMID: 34899721 DOI: 10.3389/fimmu.2021.771201] [Reference Citation Analysis]
174 Esteban E, Exposito F, Crespo G, Lambea J, Pinto A, Puente J, Arranz JA, Redrado M, Rodriguez-Antona C, de Andrea C, Lopez-Brea M, Redin E, Rodriguez A, Serrano D, Garcia J, Grande E, Castellano D, Calvo A. Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers (Basel) 2021;13:2849. [PMID: 34200459 DOI: 10.3390/cancers13112849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Stalin J, Imhof BA, Coquoz O, Jeitziner R, Hammel P, McKee TA, Jemelin S, Poittevin M, Pocard M, Matthes T, Kaci R, Delorenzi M, Rüegg C, Miljkovic-Licina M. Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy. Cancers (Basel) 2021;13:4625. [PMID: 34572851 DOI: 10.3390/cancers13184625] [Reference Citation Analysis]
176 Fan X, Wang J, Qin T, Zhang Y, Liu W, Jiang K, Huang D. Exosome miR-27a-3p secreted from adipocytes targets ICOS to promote antitumor immunity in lung adenocarcinoma. Thorac Cancer 2020;11:1453-64. [PMID: 32212417 DOI: 10.1111/1759-7714.13411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Diez-quijada L, Casas-rodriguez A, Guzmán-guillén R, Molina-hernández V, Albaladejo RG, Cameán AM, Jos A. Immunomodulatory Effects of Pure Cylindrospermopsin in Rats Orally Exposed for 28 Days. Toxins 2022;14:144. [DOI: 10.3390/toxins14020144] [Reference Citation Analysis]
178 Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Reference Citation Analysis]
179 Gaire B, Uddin MM, Zou Y, Vancurova I. Analysis of IFNγ-Induced Migration of Ovarian Cancer Cells. Methods Mol Biol 2020;2108:101-6. [PMID: 31939173 DOI: 10.1007/978-1-0716-0247-8_8] [Reference Citation Analysis]
180 Yakubogullari N, Coven FO, Cebi N, Coven F, Coven N, Genc R, Bedir E, Nalbantsoy A. Evaluation of adjuvant activity of Astragaloside VII and its combination with different immunostimulating agents in Newcastle Disease vaccine. Biologicals 2021;70:28-37. [PMID: 33608170 DOI: 10.1016/j.biologicals.2021.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
181 Shen C, Ye W, Gong L, Lv K, Gao B, Yao H. Serum interleukin-6, interleukin-17A, and tumor necrosis factor-alpha in patients with recurrent aphthous stomatitis. J Oral Pathol Med 2021;50:418-23. [PMID: 33432616 DOI: 10.1111/jop.13158] [Reference Citation Analysis]
182 Poli-Neto OB, Meola J, Rosa-E-Silva JC, Tiezzi D. Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu. Sci Rep 2020;10:313. [PMID: 31941945 DOI: 10.1038/s41598-019-57207-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
183 Refae S, Gal J, Ebran N, Otto J, Borchiellini D, Peyrade F, Chamorey E, Brest P, Milano G, Saada-Bouzid E. Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors. Invest New Drugs 2020;38:160-71. [PMID: 31402427 DOI: 10.1007/s10637-019-00845-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
184 Gaudino SJ, Kumar P. Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis. Front Immunol 2019;10:360. [PMID: 30894857 DOI: 10.3389/fimmu.2019.00360] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 20.3] [Reference Citation Analysis]
185 Lee Y, Kim CH. Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives. Arch Pharm Res 2019;42:607-16. [DOI: 10.1007/s12272-019-01136-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
186 Jain M, Singh MK, Shyam H, Mishra A, Kumar S, Kumar A, Kushwaha J. Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders. Annals of Neurosciences. [DOI: 10.1177/09727531211070532] [Reference Citation Analysis]
187 Hauptstein N, Meinel L, Lühmann T. Bioconjugation strategies and clinical implications of Interferon-bioconjugates. Eur J Pharm Biopharm 2022:S0939-6411(22)00027-3. [PMID: 35149191 DOI: 10.1016/j.ejpb.2022.02.006] [Reference Citation Analysis]
188 Reis-Sobreiro M, Teixeira da Mota A, Jardim C, Serre K. Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages. Cells 2021;10:2364. [PMID: 34572013 DOI: 10.3390/cells10092364] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Andreu-Ballester JC, Galindo-Regal L, Hidalgo-Coloma J, Cuéllar C, García-Ballesteros C, Hurtado C, Uribe N, Del Carmen Martín M, Jiménez AI, López-Chuliá F, Llombart-Cussac A. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors. PLoS One 2020;15:e0243545. [PMID: 33326443 DOI: 10.1371/journal.pone.0243545] [Reference Citation Analysis]
190 Kwon R, Hong BK, Lee KG, Choi E, Sabbagh L, Cho CS, Lee N, Kim WU. Regulation of tumor growth by leukocyte-specific protein 1 in T cells. J Immunother Cancer 2020;8:e001180. [PMID: 33020243 DOI: 10.1136/jitc-2020-001180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Kothari A, Jagannath B, Muthukumar S, Prasad S. An observational study for detection and quantification of interferon- γ in sweat toward inflammation monitoring. Biosensors and Bioelectronics: X 2022;10:100122. [DOI: 10.1016/j.biosx.2022.100122] [Reference Citation Analysis]
192 Ma KY, Schonnesen AA, Brock A, Van Den Berg C, Eckhardt SG, Liu Z, Jiang N. Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes. JCI Insight. 2019;4. [PMID: 30821712 DOI: 10.1172/jci.insight.121387] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
193 Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. Int Rev Immunol 2021;40:197-216. [PMID: 33258393 DOI: 10.1080/08830185.2020.1845670] [Reference Citation Analysis]
194 Kim SJ, Lee J, Choi WS, Kim HJ, Kim MY, Kim SC, Kim HS. Ginsenoside F1 Attenuates Eosinophilic Inflammation in Chronic Rhinosinusitis by Promoting NK Cell Function. J Ginseng Res 2021;45:695-705. [PMID: 34764724 DOI: 10.1016/j.jgr.2021.03.007] [Reference Citation Analysis]
195 Huang HW, Chang CC, Wang CS, Lin KH. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development. Cells 2021;10:E67. [PMID: 33406733 DOI: 10.3390/cells10010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
196 Mortezaee K, Majidpoor J. Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy. Cell Oncol (Dordr) 2022. [PMID: 35587857 DOI: 10.1007/s13402-022-00667-8] [Reference Citation Analysis]
197 Feng PH, Wang X, Ferrall L, Wu TC, Hung CF. Control of Tumors by Antigen-Specific CD8+ T Cells through PDL1-Targeted Delivery of Antigenic Peptide. J Immunol Res 2022;2022:9054569. [PMID: 35028321 DOI: 10.1155/2022/9054569] [Reference Citation Analysis]
198 Zhang J, He T, Xue L, Guo H. Senescent T cells: a potential biomarker and target for cancer therapy. EBioMedicine 2021;68:103409. [PMID: 34049248 DOI: 10.1016/j.ebiom.2021.103409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Lee J, Lozano-Ruiz B, Yang FM, Fan DD, Shen L, González-Navajas JM. The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy. Front Immunol 2021;12:625667. [PMID: 33777008 DOI: 10.3389/fimmu.2021.625667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
200 Toda Y, Kohashi K, Yamada Y, Yoshimoto M, Ishihara S, Ito Y, Iwasaki T, Yamamoto H, Matsumoto Y, Nakashima Y, Mawatari M, Oda Y. PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions. J Cancer Res Clin Oncol 2020;146:2607-20. [PMID: 32388585 DOI: 10.1007/s00432-020-03242-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
201 Kong R, Wang N, Han W, Bao W, Lu J. IFNγ-mediated repression of system xc- drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol 2021;110:301-14. [PMID: 34318944 DOI: 10.1002/JLB.3MA1220-815RRR] [Reference Citation Analysis]
202 Komel T, Bosnjak M, Kranjc Brezar S, De Robertis M, Mastrodonato M, Scillitani G, Pesole G, Signori E, Sersa G, Cemazar M. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma. Bioelectrochemistry 2021;141:107843. [PMID: 34139572 DOI: 10.1016/j.bioelechem.2021.107843] [Reference Citation Analysis]
203 Han S, Shuen WH, Wang WW, Nazim E, Toh HC. Tailoring precision immunotherapy: coming to a clinic soon? ESMO Open 2020;5 Suppl 1:e000631. [PMID: 33558033 DOI: 10.1136/esmoopen-2019-000631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
204 Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG. Trial watch: intratumoral immunotherapy. Oncoimmunology 2021;10:1984677. [PMID: 34676147 DOI: 10.1080/2162402X.2021.1984677] [Reference Citation Analysis]
205 Dai YH, Wang YF, Shen PC, Lo CH, Yang JF, Lin CS, Chao HL, Huang WY. Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy. NPJ Genom Med 2021;6:40. [PMID: 34078917 DOI: 10.1038/s41525-021-00200-0] [Reference Citation Analysis]
206 Vijayakumar S, Viswanathan S, Aghoram R. Idiopathic CD4 Lymphocytopenia: Current Insights. Immunotargets Ther 2020;9:79-93. [PMID: 32548074 DOI: 10.2147/ITT.S214139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
207 Knopick P, Terman D, Riha N, Alvine T, Larson R, Badiou C, Lina G, Ballantyne J, Bradley D. Endogenous HLA-DQ8αβ programs superantigens (SEG/SEI) to silence toxicity and unleash a tumoricidal network with long-term melanoma survival. J Immunother Cancer 2020;8:e001493. [PMID: 33109631 DOI: 10.1136/jitc-2020-001493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Rosi E, Fastame MT, Scandagli I, Di Cesare A, Ricceri F, Pimpinelli N, Prignano F. Insights into the Pathogenesis of HS and Therapeutical Approaches. Biomedicines 2021;9:1168. [PMID: 34572354 DOI: 10.3390/biomedicines9091168] [Reference Citation Analysis]
209 Jiang L, Liu JY, Shi Y, Tang B, He T, Liu JJ, Fan JY, Wu B, Xu XH, Zhao YL, Qian F, Cui YH, Yu PW. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling. J Exp Clin Cancer Res 2019;38:206. [PMID: 31113461 DOI: 10.1186/s13046-019-1186-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
210 Mittal D, Vijayan D, Neijssen J, Kreijtz J, Habraken MMJM, Van Eenennaam H, Van Elsas A, Smyth MJ. Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy. Oncoimmunology 2019;8:e1648171. [PMID: 31646095 DOI: 10.1080/2162402X.2019.1648171] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
211 Sirobhushanam S, Lazar S, Kahlenberg JM. Interferons in Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2021;47:297-315. [PMID: 34215365 DOI: 10.1016/j.rdc.2021.04.001] [Reference Citation Analysis]
212 Ma W, Pham B, Li T. Cancer neoantigens as potential targets for immunotherapy. Clin Exp Metastasis 2021. [PMID: 33950415 DOI: 10.1007/s10585-021-10091-1] [Reference Citation Analysis]
213 Daman AW, Josefowicz SZ. Epigenetic and transcriptional control of interferon-β. J Exp Med 2021;218:e20210039. [PMID: 34297037 DOI: 10.1084/jem.20210039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 Zeng Z, Veitch M, Kelly GA, Tuong ZK, Cruz JG, Frazer IH, Wells JW. IFN-γ Critically Enables the Intratumoural Infiltration of CXCR3+ CD8+ T Cells to Drive Squamous Cell Carcinoma Regression. Cancers (Basel) 2021;13:2131. [PMID: 33925140 DOI: 10.3390/cancers13092131] [Reference Citation Analysis]
215 Lu Y, Zhang J, Chen Y, Kang Y, Liao Z, He Y, Zhang C. Novel Immunotherapies for Osteosarcoma. Front Oncol 2022;12:830546. [DOI: 10.3389/fonc.2022.830546] [Reference Citation Analysis]
216 Ju SA, Park SM, Joe Y, Chung HT, An WG, Kim BS. Anti-4-1BB antibody-based combination therapy augments antitumor immunity by enhancing CD11c+CD8+ T cells in renal cell carcinoma. Oncol Lett 2022;23:43. [PMID: 34976155 DOI: 10.3892/ol.2021.13161] [Reference Citation Analysis]
217 Ahn SS, Kim HW, Park Y. Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases. J Clin Med 2021;10:4357. [PMID: 34640376 DOI: 10.3390/jcm10194357] [Reference Citation Analysis]
218 Workenhe ST, Pol J, Kroemer G. Tumor-intrinsic determinants of immunogenic cell death modalities. Oncoimmunology 2021;10:1893466. [PMID: 33717656 DOI: 10.1080/2162402X.2021.1893466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
219 Mahdevar E, Safavi A, Abiri A, Kefayat A, Hejazi SH, Miresmaeili SM, Iranpur Mobarakeh V. Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches. J Biomol Struct Dyn 2021;:1-18. [PMID: 33599191 DOI: 10.1080/07391102.2021.1883111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Ebrahimiyan H, Tamimi A, Shokoohian B, Minaei N, Memarnejadian A, Hossein-Khannazer N, Hassan M, Vosough M. Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages. Int Immunopharmacol 2022;106:108587. [PMID: 35149294 DOI: 10.1016/j.intimp.2022.108587] [Reference Citation Analysis]
221 Brisse M, Huang Q, Rahman M, Di D, Liang Y, Ly H. RIG-I and MDA5 Protect Mice From Pichinde Virus Infection by Controlling Viral Replication and Regulating Immune Responses to the Infection. Front Immunol 2021;12:801811. [PMID: 34925387 DOI: 10.3389/fimmu.2021.801811] [Reference Citation Analysis]
222 Denver P, McClean PL. Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition. Neural Regen Res 2018;13:1719-30. [PMID: 30136683 DOI: 10.4103/1673-5374.238608] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
223 Li Z, Ma R, Ma S, Tian L, Lu T, Zhang J, Mundy-Bosse BL, Zhang B, Marcucci G, Caligiuri MA, Yu J. ILC1s control leukemia stem cell fate and limit development of AML. Nat Immunol 2022. [PMID: 35487987 DOI: 10.1038/s41590-022-01198-y] [Reference Citation Analysis]
224 Li BY, Tan W, Zou JL, He Y, Yoshida S, Jiang B, Zhou YD. Role of interferons in diabetic retinopathy. World J Diabetes 2021; 12(7): 939-953 [PMID: 34326947 DOI: 10.4239/wjd.v12.i7.939] [Reference Citation Analysis]
225 Schmidt R, Steinhart Z, Layeghi M, Freimer JW, Bueno R, Nguyen VQ, Blaeschke F, Ye CJ, Marson A. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science 2022;375:eabj4008. [PMID: 35113687 DOI: 10.1126/science.abj4008] [Reference Citation Analysis]
226 Gilchrist VH, Jémus-Gonzalez E, Said A, Alain T. Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy. Cytokine Growth Factor Rev 2020;56:83-93. [PMID: 32690442 DOI: 10.1016/j.cytogfr.2020.07.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Sun L, Kees T, Almeida AS, Liu B, He XY, Ng D, Han X, Spector DL, McNeish IA, Gimotty P, Adams S, Egeblad M. Activating a collaborative innate-adaptive immune response to control metastasis. Cancer Cell 2021;39:1361-1374.e9. [PMID: 34478639 DOI: 10.1016/j.ccell.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Morana O, Nieto-Garai JA, Björkholm P, Bernardino de la Serna J, Terrones O, Arboleya A, Ciceri D, Rojo-Bartolomé I, Blouin CM, Lamaze C, Lorizate M, Contreras FX. Identification of a New Cholesterol-Binding Site within the IFN-γ Receptor that is Required for Signal Transduction. Adv Sci (Weinh) 2022;:e2105170. [PMID: 35166455 DOI: 10.1002/advs.202105170] [Reference Citation Analysis]
229 De Re V, Caggiari L, Repetto O, Mussolin L, Mascarin M. Classical Hodgkin's Lymphoma in the Era of Immune Checkpoint Inhibition. J Clin Med 2019;8:E1596. [PMID: 31581738 DOI: 10.3390/jcm8101596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
230 Apollonio B, Ioannou N, Papazoglou D, Ramsay AG. Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy. Front Oncol 2021;11:626818. [PMID: 33842331 DOI: 10.3389/fonc.2021.626818] [Reference Citation Analysis]
231 Trofimova O, Korotkaja K, Skrastina D, Jansons J, Spunde K, Isaguliants M, Zajakina A. Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model. Vaccines (Basel) 2021;9:1247. [PMID: 34835178 DOI: 10.3390/vaccines9111247] [Reference Citation Analysis]
232 Pezeshki PS, Mahdavi Sharif P, Rezaei N. Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors. Expert Opin Biol Ther 2021;:1-16. [PMID: 33984254 DOI: 10.1080/14712598.2021.1929919] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Terpinskaya TI, Osipov AV, Balashevich TV, Yanchanka TL, Tamashionik EA, Tsetlin VI, Utkin YN. Blockers of Nicotinic Acetylcholine Receptors Delay Tumor Growth and Increase Antitumor Activity of Mouse Splenocytes. Dokl Biochem Biophys 2020;491:89-92. [PMID: 32483759 DOI: 10.1134/S1607672920020143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Hatic H, Sampat D, Goyal G. Immune checkpoint inhibitors in lymphoma: challenges and opportunities. Ann Transl Med 2021;9:1037. [PMID: 34277837 DOI: 10.21037/atm-20-6833] [Reference Citation Analysis]
235 Zaiachuk M, Pryimak N, Kovalchuk O, Kovalchuk I. Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy. Front Med (Lausanne) 2021;8:713153. [PMID: 34631734 DOI: 10.3389/fmed.2021.713153] [Reference Citation Analysis]
236 Zhang N, Ge M, Jiang T, Peng X, Sun H, Qi X, Zou Z, Li D. An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma. Front Oncol 2021;11:592211. [PMID: 33928021 DOI: 10.3389/fonc.2021.592211] [Reference Citation Analysis]
237 Pyo KH, Lim SM, Park CW, Jo HN, Kim JH, Yun MR, Kim D, Xin CF, Lee W, Gheorghiu B, Hong MH, Kim HR, Shim HS, Jang M, Lee SS, Cho BC. Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer. J Immunother Cancer 2020;8:e000970. [PMID: 32727812 DOI: 10.1136/jitc-2020-000970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
238 Liu L, Du X, Fang J, Zhao J, Guo Y, Zhao Y, Zou C, Yan X, Li W. Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma. J Inflamm Res 2021;14:4969-85. [PMID: 34611422 DOI: 10.2147/JIR.S334041] [Reference Citation Analysis]
239 Mustafa G, Mahrosh HS, Salman M, Sharif S, Jabeen R, Majeed T, Tahir H. Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus. Biomed Res Int 2021;2021:1124055. [PMID: 34812407 DOI: 10.1155/2021/1124055] [Reference Citation Analysis]
240 Gupta VK, Kumar A. Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response. Apoptosis 2022. [PMID: 35366141 DOI: 10.1007/s10495-022-01723-2] [Reference Citation Analysis]
241 Casella G, Rasouli J, Thome R, Descamps HC, Vattikonda A, Ishikawa L, Boehm A, Hwang D, Zhang W, Xiao D, Park J, Zhang GX, Alvarez JI, Rostami A, Ciric B. Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity. Front Immunol 2020;11:576752. [PMID: 33193372 DOI: 10.3389/fimmu.2020.576752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
242 Lieverse RIY, Marcus D, van der Wiel AMA, Van Limbergen EJ, Theys J, Yaromina A, Lambin P, Dubois LJ. Human fibronectin extra domain B as a biomarker for targeted therapy in cancer. Mol Oncol 2020;14:1555-68. [PMID: 32386436 DOI: 10.1002/1878-0261.12705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
243 Chung YM, Khan PP, Wang H, Tsai WB, Qiao Y, Yu B, Larrick JW, Hu MC. Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3. J Immunother Cancer 2021;9:e002772. [PMID: 34887262 DOI: 10.1136/jitc-2021-002772] [Reference Citation Analysis]
244 Mei KC, Liao YP, Jiang J, Chiang M, Khazaieli M, Liu X, Wang X, Liu Q, Chang CH, Zhang X, Li J, Ji Y, Melano B, Telesca D, Xia T, Meng H, Nel AE. Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors. ACS Nano 2020;14:13343-66. [PMID: 32940463 DOI: 10.1021/acsnano.0c05194] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
245 Ding P, Ma Z, Liu D, Pan M, Li H, Feng Y, Zhang Y, Shao C, Jiang M, Lu D, Han J, Wang J, Yan X. Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy. Front Immunol 2022;13:865975. [DOI: 10.3389/fimmu.2022.865975] [Reference Citation Analysis]
246 Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, Fereirra JP, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Metra M, Samani NJ, de Boer RA, van Veldhuisen DJ, Voors AA, van der Meer P; BIOSTAT-CHF Consortium. Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF. Cardiovasc Res 2021:cvab235. [PMID: 34264317 DOI: 10.1093/cvr/cvab235] [Reference Citation Analysis]
247 Samson JM, Ravindran Menon D, Smith DE, Baird E, Kitano T, Gao D, Tan AC, Fujita M. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes. Chem Biol Interact 2019;314:108822. [PMID: 31580832 DOI: 10.1016/j.cbi.2019.108822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
248 Xia Y, Huang S, Wang Y, Lei D, Wang Y, Yang H, Gao Y, Liu P. Prognostication of Primary Tumor Location in Early-Stage Nodal Diffuse Large B-Cell Lymphoma: An Analysis of the SEER Database. Cancers (Basel) 2021;13:3954. [PMID: 34439110 DOI: 10.3390/cancers13163954] [Reference Citation Analysis]
249 Parakrama R, Fogel E, Chandy C, Augustine T, Coffey M, Tesfa L, Goel S, Maitra R. Immune characterization of metastatic colorectal cancer patients post reovirus administration. BMC Cancer 2020;20:569. [PMID: 32552875 DOI: 10.1186/s12885-020-07038-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
250 Ongaro T, Guarino SR, Scietti L, Palamini M, Wulhfard S, Neri D, Villa A, Forneris F. Inference of molecular structure for characterization and improvement of clinical grade immunocytokines. J Struct Biol 2021;213:107696. [PMID: 33493635 DOI: 10.1016/j.jsb.2021.107696] [Reference Citation Analysis]
251 Baram T, Rubinstein-Achiasaf L, Ben-Yaakov H, Ben-Baruch A. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Front Oncol 2020;10:614468. [PMID: 33585241 DOI: 10.3389/fonc.2020.614468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
252 Nel AE, Mei KC, Liao YP, Liu X. Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs. ACS Nano 2022. [PMID: 35348320 DOI: 10.1021/acsnano.2c01252] [Reference Citation Analysis]
253 Hwang M, Bergmann CC. Neuronal Ablation of Alpha/Beta Interferon (IFN-α/β) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-γ Responsiveness in Microglia/Macrophages. J Virol 2020;94:e00422-20. [PMID: 32796063 DOI: 10.1128/JVI.00422-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
254 Kiritsy MC, McCann K, Mott D, Holland SM, Behar SM, Sassetti CM, Olive AJ. Mitochondrial respiration contributes to the interferon gamma response in antigen-presenting cells. Elife 2021;10:e65109. [PMID: 34726598 DOI: 10.7554/eLife.65109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Alhawmdeh M, Isreb M, Aziz A, Jacob BK, Anderson D, Najafzadeh M. Interferon-γ liposome: a new system to improve drug delivery in the treatment of lung cancer. ERJ Open Res 2021;7:00555-2020. [PMID: 34435034 DOI: 10.1183/23120541.00555-2020] [Reference Citation Analysis]
256 Chrisikos TT, Zhou Y, Li HS, Babcock RL, Wan X, Patel B, Newton K, Mancuso JJ, Watowich SS. STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer. Cancers (Basel) 2020;12:E128. [PMID: 31947933 DOI: 10.3390/cancers12010128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
257 Cornel AM, Mimpen IL, Nierkens S. MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy. Cancers (Basel) 2020;12:E1760. [PMID: 32630675 DOI: 10.3390/cancers12071760] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 16.0] [Reference Citation Analysis]
258 Fan YM, Zhang YL, Luo H, Mohamud Y. Crosstalk between RNA viruses and DNA sensors: Role of the cGAS‐STING signalling pathway. Reviews in Medical Virology. [DOI: 10.1002/rmv.2343] [Reference Citation Analysis]
259 Petralia MC, Mazzon E, Fagone P, Basile MS, Lenzo V, Quattropani MC, Di Nuovo S, Bendtzen K, Nicoletti F. The cytokine network in the pathogenesis of major depressive disorder. Close to translation? Autoimmun Rev 2020;19:102504. [PMID: 32173514 DOI: 10.1016/j.autrev.2020.102504] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
260 Wang L, Gong W, Wang S, Neuber B, Sellner L, Schubert ML, Hückelhoven-Krauss A, Kunz A, Gern U, Michels B, Hinkelbein M, Mechler S, Richter P, Müller-Tidow C, Schmitt M, Schmitt A. Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells. Cytotherapy 2019;21:566-78. [PMID: 30910382 DOI: 10.1016/j.jcyt.2019.02.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
261 Huffaker TB, Ekiz HA, Barba C, Lee SH, Runtsch MC, Nelson MC, Bauer KM, Tang WW, Mosbruger TL, Cox JE, Round JL, Voth WP, O'Connell RM. A Stat1 bound enhancer promotes Nampt expression and function within tumor associated macrophages. Nat Commun 2021;12:2620. [PMID: 33976173 DOI: 10.1038/s41467-021-22923-5] [Reference Citation Analysis]
262 Munhoz J, Thomé R, Rostami A, Ishikawa LLW, Verinaud L, Rapôso C. The SNX-482 peptide from Hysterocrates gigas spider acts as an immunomodulatory molecule activating macrophages. Peptides 2021;146:170648. [PMID: 34537257 DOI: 10.1016/j.peptides.2021.170648] [Reference Citation Analysis]
263 Guo L, Xie H, Zhang Z, Wang Z, Peng S, Niu Y, Shang Z. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines (Basel) 2021;9:786. [PMID: 34358202 DOI: 10.3390/vaccines9070786] [Reference Citation Analysis]
264 Gallay L, Mouchiroud G, Chazaud B. Interferon-signature in idiopathic inflammatory myopathies. Curr Opin Rheumatol 2019;31:634-42. [PMID: 31464706 DOI: 10.1097/BOR.0000000000000653] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
265 Phipps O, Brookes MJ, Al-Hassi HO. Iron deficiency, immunology, and colorectal cancer. Nutr Rev 2021;79:88-97. [PMID: 32679587 DOI: 10.1093/nutrit/nuaa040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
266 Fazzari J, Sidhu J, Motkur S, Inman M, Buckley N, Clemons M, Vandermeer L, Singh G. Applying Serum Cytokine Levels to Predict Pain Severity in Cancer Patients. J Pain Res 2020;13:313-21. [PMID: 32104053 DOI: 10.2147/JPR.S227175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
267 Hinterleitner C, Zhou Y, Tandler C, Heitmann JS, Kropp KN, Hinterleitner M, Koch A, Hartkopf AD, Zender L, Salih HR, Maurer S. Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression. Front Oncol 2021;11:642170. [PMID: 33816291 DOI: 10.3389/fonc.2021.642170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
268 Jenkins S, Wesolowski R, Gatti-Mays ME. Improving Breast Cancer Responses to Immunotherapy-a Search for the Achilles Heel of the Tumor Microenvironment. Curr Oncol Rep 2021;23:55. [PMID: 33755828 DOI: 10.1007/s11912-021-01040-y] [Reference Citation Analysis]
269 Mineo M, Lyons SM, Zdioruk M, von Spreckelsen N, Ferrer-Luna R, Ito H, Alayo QA, Kharel P, Giantini Larsen A, Fan WY, Auduong S, Grauwet K, Passaro C, Khalsa JK, Shah K, Reardon DA, Ligon KL, Beroukhim R, Nakashima H, Ivanov P, Anderson PJ, Lawler SE, Chiocca EA. Tumor Interferon Signaling Is Regulated by a lncRNA INCR1 Transcribed from the PD-L1 Locus. Mol Cell 2020;78:1207-1223.e8. [PMID: 32504554 DOI: 10.1016/j.molcel.2020.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
270 De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A, Colombo MP, Di Virgilio F, Adinolfi E. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene 2019;38:3636-50. [PMID: 30655604 DOI: 10.1038/s41388-019-0684-y] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 24.0] [Reference Citation Analysis]
271 Yao B, Wang L, Wang H, Bao J, Li Q, Yu F, Zhu W, Zhang L, Li W, Gu Z, Fei K, Zhang P, Zhang F, Huang X. Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma. Aging (Albany NY) 2021;13:11381-410. [PMID: 33839701 DOI: 10.18632/aging.202831] [Reference Citation Analysis]
272 Liu J, Tokheim C, Lee JD, Gan W, North BJ, Liu XS, Pandolfi PP, Wei W. Genetic fusions favor tumorigenesis through degron loss in oncogenes. Nat Commun 2021;12:6704. [PMID: 34795215 DOI: 10.1038/s41467-021-26871-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Sparger EE, Chang H, Chin N, Rebhun RB, Withers SS, Kieu H, Canter RJ, Monjazeb AM, Kent MS. T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma. Front Vet Sci 2021;8:772932. [PMID: 34926643 DOI: 10.3389/fvets.2021.772932] [Reference Citation Analysis]
274 Ghaffari-nazari H, Alimohammadi M, Alimohammadi R, Rostami E, Bakhshandeh M, Webster TJ, Mahmoodi Chalbatani G, Tavakkol-afshari J, Amir Jalali S. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model. International Immunopharmacology 2022;108:108737. [DOI: 10.1016/j.intimp.2022.108737] [Reference Citation Analysis]
275 Rochet E, Appukuttan B, Ma Y, Ashander LM, Smith JR. Expression of Long Non-Coding RNAs by Human Retinal Müller Glial Cells Infected with Clonal and Exotic Virulent Toxoplasma gondii. Noncoding RNA 2019;5:E48. [PMID: 31547203 DOI: 10.3390/ncrna5040048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
276 Ramos TI, Villacis-Aguirre CA, Santiago Vispo N, Santiago Padilla L, Pedroso Santana S, Parra NC, Alonso JRT. Forms and Methods for Interferon's Encapsulation. Pharmaceutics 2021;13:1533. [PMID: 34683824 DOI: 10.3390/pharmaceutics13101533] [Reference Citation Analysis]
277 Goto H, Sugita K, Yamamoto O. Interstitial granuloma after interferon-gamma and narrowband UVB therapy in a patient with mycosis fungoides: Immunological and histopathological considerations. J Cutan Pathol 2021;48:689-93. [PMID: 33442885 DOI: 10.1111/cup.13960] [Reference Citation Analysis]
278 Deyell M, Garris CS, Laughney AM. Cancer metastasis as a non-healing wound. Br J Cancer 2021;124:1491-502. [PMID: 33731858 DOI: 10.1038/s41416-021-01309-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
279 Zhang M, Huang L, Ding G, Huang H, Cao G, Sun X, Lou N, Wei Q, Shen T, Xu X, Cao L, Yan Q. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer 2020;8:e000308. [PMID: 32051287 DOI: 10.1136/jitc-2019-000308] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
280 Huang W, Yun T, Chew C, Chen A, Wei P, Lee K, Lee H, Feng P, Chiou J, Chen C, Chen C. Microtube Array Membrane Hollow Fiber Assay (MTAM-HFA)—An Accurate and Rapid Potential Companion Diagnostic and Pharmacological Interrogation Solution for Cancer Immunotherapy (PD-1/PD-L1). Biomolecules 2022;12:480. [DOI: 10.3390/biom12040480] [Reference Citation Analysis]
281 Raverdeau M, Cunningham SP, Harmon C, Lynch L. γδ T cells in cancer: a small population of lymphocytes with big implications. Clin Transl Immunology 2019;8:e01080. [PMID: 31624593 DOI: 10.1002/cti2.1080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
282 Silva C, Andrade N, Rodrigues I, Ferreira AC, Soares ML, Martel F. The pro-proliferative effect of interferon-γ in breast cancer cell lines is dependent on stimulation of ASCT2-mediated glutamine cellular uptake. Life Sci 2021;286:120054. [PMID: 34662550 DOI: 10.1016/j.lfs.2021.120054] [Reference Citation Analysis]
283 Qiu Y, Su M, Liu L, Tang Y, Pan Y, Sun J. Clinical Application of Cytokines in Cancer Immunotherapy. Drug Des Devel Ther 2021;15:2269-87. [PMID: 34079226 DOI: 10.2147/DDDT.S308578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Aasvang EK, Pitter S, Hansen CP, Storkholm JH, Krohn PS, Burgdorf SK, Von Stemann JH, Lundgren JD, Nielsen SD, Kehlet H, Ostrowski SR. Preoperative TruCulture® whole blood cytokine response predicts post-operative inflammation in pancreaticoduodenectomy patients-A pilot cohort study. Scand J Immunol 2020;92:e12930. [PMID: 32640052 DOI: 10.1111/sji.12930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
285 Marchini A, Daeffler L, Pozdeev VI, Angelova A, Rommelaere J. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.Front Immunol. 2019;10:1848. [PMID: 31440242 DOI: 10.3389/fimmu.2019.01848] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
286 Setlai BP, Hull R, Bida M, Durandt C, Mulaudzi TV, Chatziioannou A, Dlamini Z. Immunosuppressive Signaling Pathways as Targeted Cancer Therapies. Biomedicines 2022;10:682. [DOI: 10.3390/biomedicines10030682] [Reference Citation Analysis]
287 Ravindran Menon D, Li Y, Yamauchi T, Osborne DG, Vaddi PK, Wempe MF, Zhai Z, Fujita M. EGCG Inhibits Tumor Growth in Melanoma by Targeting JAK-STAT Signaling and Its Downstream PD-L1/PD-L2-PD1 Axis in Tumors and Enhancing Cytotoxic T-Cell Responses. Pharmaceuticals (Basel) 2021;14:1081. [PMID: 34832863 DOI: 10.3390/ph14111081] [Reference Citation Analysis]
288 Zhou Y, Ou L, Xu J, Yuan H, Luo J, Shi B, Li X, Yang S, Wang Y. FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer. Cell Death Dis 2021;12:668. [PMID: 34215720 DOI: 10.1038/s41419-021-03933-z] [Reference Citation Analysis]
289 Roberts A, Bentley L, Tang T, Stewart F, Pallini C, Juvvanapudi J, Wallace GR, Cooper AJ, Scott A, Thickett D, Lugg ST, Bancroft H, Hemming B, Ferris C, Langman G, Robinson A, Chapman J, Naidu B, Pinkney T, Taylor GS, Brock K, Stamataki Z, Brady CA, Curnow SJ, Gordon J, Qureshi O, Barnes NM. Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation. Sci Rep 2021;11:4030. [PMID: 33597595 DOI: 10.1038/s41598-021-83612-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Rostamian H, Khakpoor-Koosheh M, Jafarzadeh L, Masoumi E, Fallah-Mehrjardi K, Tavassolifar MJ, M Pawelek J, Mirzaei HR, Hadjati J. Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions. BMC Cancer 2022;22:39. [PMID: 34991504 DOI: 10.1186/s12885-021-09151-2] [Reference Citation Analysis]
291 Badowski C, San Tan T, Aliev T, Trudil D, Larina M, Argentova V, Firdaus MJ, Benny P, Woo VS, Lane EB. Detrimental effects of IFNγ on an epidermolysis bullosa simplex cell model and protection by a humanized anti-IFNγ monoclonal antibody. JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100096] [Reference Citation Analysis]
292 Burke JD, Young HA. IFN-γ: A cytokine at the right time, is in the right place. Semin Immunol 2019;43:101280. [PMID: 31221552 DOI: 10.1016/j.smim.2019.05.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
293 Carbotti G, Petretto A, Naschberger E, Stürzl M, Martini S, Mingari MC, Filaci G, Ferrini S, Fabbi M. Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells. Cancers (Basel) 2020;12:E488. [PMID: 32093058 DOI: 10.3390/cancers12020488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
294 Arnesen H, Hitch TCA, Steppeler C, Müller MHB, Knutsen LE, Gunnes G, Angell IL, Ormaasen I, Rudi K, Paulsen JE, Clavel T, Carlsen H, Boysen P. Naturalizing laboratory mice by housing in a farmyard-type habitat confers protection against colorectal carcinogenesis. Gut Microbes 2021;13:1993581. [PMID: 34751603 DOI: 10.1080/19490976.2021.1993581] [Reference Citation Analysis]
295 Shen Y, Sun Z, Mao S, Zhang Y, Jiang W, Wang H. IRF-1 contributes to the pathological phenotype of VSMCs during atherogenesis by increasing CCL19 transcription. Aging (Albany NY) 2020;13:933-43. [PMID: 33424012 DOI: 10.18632/aging.202204] [Reference Citation Analysis]
296 Aindelis G, Tiptiri-Kourpeti A, Lampri E, Spyridopoulou K, Lamprianidou E, Kotsianidis I, Ypsilantis P, Pappa A, Chlichlia K. Immune Responses Raised in an Experimental Colon Carcinoma Model Following Oral Administration of Lactobacillus casei. Cancers (Basel) 2020;12:E368. [PMID: 32033490 DOI: 10.3390/cancers12020368] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
297 Gmeiner WH. Fluoropyrimidine Modulation of the Anti-Tumor Immune Response-Prospects for Improved Colorectal Cancer Treatment. Cancers (Basel) 2020;12:E1641. [PMID: 32575843 DOI: 10.3390/cancers12061641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
298 Vaes RDW, Reynders K, Sprooten J, Nevola KT, Rouschop KMA, Vooijs M, Garg AD, Lambrecht M, Hendriks LEL, Rucevic M, De Ruysscher D. Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study. Cancers (Basel) 2021;13:6259. [PMID: 34944879 DOI: 10.3390/cancers13246259] [Reference Citation Analysis]
299 Baker AT, Abuwarwar MH, Poly L, Wilkins S, Fletcher AL. Cancer-Associated Fibroblasts and T Cells: From Mechanisms to Outcomes. J Immunol 2021;206:310-20. [PMID: 33397745 DOI: 10.4049/jimmunol.2001203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
300 Maggs L, Sadagopan A, Moghaddam AS, Ferrone S. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy. Trends Cancer 2021;7:1089-101. [PMID: 34489208 DOI: 10.1016/j.trecan.2021.07.006] [Reference Citation Analysis]
301 Das D, Karthik N, Taneja R. Crosstalk Between Inflammatory Signaling and Methylation in Cancer. Front Cell Dev Biol 2021;9:756458. [PMID: 34901003 DOI: 10.3389/fcell.2021.756458] [Reference Citation Analysis]
302 Robert C, Tsiampali J, Fraser-Miller SJ, Neumann S, Maciaczyk D, Young SL, Maciaczyk J, Gordon KC. Molecular monitoring of glioblastoma's immunogenicity using a combination of Raman spectroscopy and chemometrics. Spectrochim Acta A Mol Biomol Spectrosc 2021;252:119534. [PMID: 33588367 DOI: 10.1016/j.saa.2021.119534] [Reference Citation Analysis]
303 Holder PG, Lim SA, Huang CS, Sharma P, Dagdas Y, Bulutoglu B, Sockolosky JT. Engineering interferons and interleukins for cancer immunotherapy. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114112] [Reference Citation Analysis]
304 Bębnowska D, Hrynkiewicz R, Grywalska E, Pasiarski M, Sosnowska-Pasiarska B, Smarz-Widelska I, Góźdź S, Roliński J, Niedźwiedzka-Rystwej P. Immunological Prognostic Factors in Multiple Myeloma. Int J Mol Sci 2021;22:3587. [PMID: 33808304 DOI: 10.3390/ijms22073587] [Reference Citation Analysis]
305 Guptill JT, Barfield R, Chan C, Russo MA, Emmett D, Raja S, Massey JM, Juel VC, Hobson-Webb LD, Gable KL, Gonzalez N, Hammett A, Howard JF Jr, Chopra M, Kaminski HJ, Siddiqi ZA, Migdal M, Yi JS. Reduced plasmablast frequency is associated with seronegative myasthenia gravis. Muscle Nerve 2021;63:577-85. [PMID: 33294984 DOI: 10.1002/mus.27140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
306 Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-γ in tumor progression and regression: a review. Biomark Res 2020;8:49. [PMID: 33005420 DOI: 10.1186/s40364-020-00228-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
307 Kohandel Z, Farkhondeh T, Aschner M, Pourbagher-Shahri AM, Samarghandian S. Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases. Biomed Pharmacother 2021;145:112179. [PMID: 34736076 DOI: 10.1016/j.biopha.2021.112179] [Reference Citation Analysis]
308 Ullrich KA, Schulze LL, Paap EM, Müller TM, Neurath MF, Zundler S. Immunology of IL-12: An update on functional activities and implications for disease. EXCLI J 2020;19:1563-89. [PMID: 33408595 DOI: 10.17179/excli2020-3104] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
309 Wang J, Peng C, Guranich C, Heng YJ, Baker GM, Rubadue CA, Glass K, Eliassen AH, Tamimi RM, Polyak K, Hankinson S. Early-Life Body Adiposity and the Breast Tumor Transcriptome. J Natl Cancer Inst 2021;113:778-84. [PMID: 33136151 DOI: 10.1093/jnci/djaa169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
310 Mauldin IS, Jo J, Wages NA, Yogendran LV, Mahmutovic A, Young SJ, Lopes MB, Slingluff CL, Erickson LD, Fadul CE. Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma. Cells 2021;10:3378. [DOI: 10.3390/cells10123378] [Reference Citation Analysis]
311 Zalfa C, Paust S. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy. Front Immunol 2021;12:633205. [PMID: 34025641 DOI: 10.3389/fimmu.2021.633205] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
312 Heo G, Lee Y, Im E. Interplay between the Gut Microbiota and Inflammatory Mediators in the Development of Colorectal Cancer. Cancers (Basel) 2021;13:734. [PMID: 33578830 DOI: 10.3390/cancers13040734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
313 Gimeno L, Serrano-López EM, Campillo JA, Cánovas-Zapata MA, Acuña OS, García-Cózar F, Martínez-Sánchez MV, Martínez-Hernández MD, Soto-Ramírez MF, López-Cubillana P, Martínez-Escribano J, Martínez-García J, Corbalan-García S, Álvarez-López MR, Minguela A. KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers (Basel) 2020;12:E2991. [PMID: 33076479 DOI: 10.3390/cancers12102991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Kumar AS, Kamalasanan K. Drug delivery to optimize angiogenesis imbalance in keloid: A review. J Control Release 2021;329:1066-76. [PMID: 33091533 DOI: 10.1016/j.jconrel.2020.10.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
315 Filardo S, Di Pietro M, Frasca F, Diaco F, Scordio M, Antonelli G, Scagnolari C, Sessa R. Potential IFNγ Modulation of Inflammasome Pathway in Chlamydia trachomatis Infected Synovial Cells. Life (Basel) 2021;11:1359. [PMID: 34947890 DOI: 10.3390/life11121359] [Reference Citation Analysis]
316 Zhang Z, Liu L, Ma C, Cui X, Lam RHW, Chen W. An in silico glioblastoma microenvironment model dissects the immunological mechanisms of resistance to PD-1 checkpoint blockade immunotherapy. Small Methods 2021;5:2100197. [PMID: 34423116 DOI: 10.1002/smtd.202100197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
317 Carlsen L, Huntington KE, El-deiry WS. Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. Cancers 2022;14:1028. [DOI: 10.3390/cancers14041028] [Reference Citation Analysis]
318 Park KS, Nam J, Son S, Moon JJ. Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells. Biomaterials 2021;274:120844. [PMID: 33962217 DOI: 10.1016/j.biomaterials.2021.120844] [Reference Citation Analysis]
319 Zeng Z, Chew HY, Cruz JG, Leggatt GR, Wells JW. Investigating T Cell Immunity in Cancer: Achievements and Prospects. Int J Mol Sci 2021;22:2907. [PMID: 33809369 DOI: 10.3390/ijms22062907] [Reference Citation Analysis]
320 Qi J, Crinier A, Escalière B, Ye Y, Wang Z, Zhang T, Batista L, Liu H, Hong L, Wu N, Zhang M, Chen L, Liu Y, Shen L, Narni-Mancinelli E, Vivier E, Su B. Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression. Cell Rep Med 2021;2:100353. [PMID: 34467243 DOI: 10.1016/j.xcrm.2021.100353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
321 Heimes AS, Härtner F, Almstedt K, Krajnak S, Lebrecht A, Battista MJ, Edlund K, Brenner W, Hasenburg A, Sahin U, Gehrmann M, Hengstler JG, Schmidt M. Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes. Int J Mol Sci 2020;21:E7178. [PMID: 33003293 DOI: 10.3390/ijms21197178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Yang Q, Huang G, Li L, Li E, Xu L. Potential Mechanism of Immune Evasion Associated with the Master Regulator ASCL2 in Microsatellite Stability in Colorectal Cancer. J Immunol Res 2021;2021:5964752. [PMID: 33628843 DOI: 10.1155/2021/5964752] [Reference Citation Analysis]
323 Guo W, Wang Y, Yang M, Wang Z, Wang Y, Chaurasia S, Wu Z, Zhang M, Yadav GS, Rathod S, Concha-Benavente F, Fernandez C, Li S, Xie W, Ferris RL, Kammula US, Lu B, Yang D. LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance. Sci Adv 2021;7:eabb3555. [PMID: 33568470 DOI: 10.1126/sciadv.abb3555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
324 Zhao Y, Cai C, Samir J, Palgen JL, Keoshkerian E, Li H, Bull RA, Luciani F, An H, Lloyd AR. Human CD8 T-stem cell memory subsets phenotypic and functional characterization are defined by expression of CD122 or CXCR3. Eur J Immunol 2021;51:1732-47. [PMID: 33844287 DOI: 10.1002/eji.202049057] [Reference Citation Analysis]
325 Padmanabhan S, Gaire B, Zou Y, Uddin MM, DeLeon D, Vancurova I. IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration. Int J Biochem Cell Biol 2021;141:106093. [PMID: 34626802 DOI: 10.1016/j.biocel.2021.106093] [Reference Citation Analysis]
326 Guia S, Narni-Mancinelli E. Helper-like Innate Lymphoid Cells in Humans and Mice. Trends Immunol 2020;41:436-52. [PMID: 32223931 DOI: 10.1016/j.it.2020.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
327 Tan G, Song H, Xu F, Cheng G. When Hepatitis B Virus Meets Interferons. Front Microbiol 2018;9:1611. [PMID: 30072974 DOI: 10.3389/fmicb.2018.01611] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
328 Li J, Yan K, Yang Y, Li H, Wang Z, Xu X. [Interleukin-17 promotes mouse hepatoma cell proliferation by antagonizing interferon-γ]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1-5. [PMID: 30692059 DOI: 10.12122/j.issn.1673-4254.2019.01.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
329 Utz B, Turpin R, Lampe J, Pouwels J, Klefström J. Assessment of the WAP-Myc mouse mammary tumor model for spontaneous metastasis. Sci Rep 2020;10:18733. [PMID: 33127915 DOI: 10.1038/s41598-020-75411-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
330 Chang MX, Xiong F. Astaxanthin and its Effects in Inflammatory Responses and Inflammation-Associated Diseases: Recent Advances and Future Directions. Molecules 2020;25:E5342. [PMID: 33207669 DOI: 10.3390/molecules25225342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
331 Bradley JH, Barwick S, Horn GQ, Ullrich E, Best B, Arnold JP, Gregg RK. Simulated microgravity-mediated reversion of murine lymphoma immune evasion. Sci Rep 2019;9:14623. [PMID: 31602007 DOI: 10.1038/s41598-019-51106-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
332 Pandey V, Fleming-Martinez A, Bastea L, Doeppler HR, Eisenhauer J, Le T, Edenfield B, Storz P. CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions. Elife 2021;10:e60646. [PMID: 34328416 DOI: 10.7554/eLife.60646] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Hammad NM, Marei A, El-Didamony G, Mortada Z, Elradi M, Afifi AHM, Kadry HM. Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy. Vaccines (Basel) 2021;9:1280. [PMID: 34835211 DOI: 10.3390/vaccines9111280] [Reference Citation Analysis]
334 Zhou B, Gao Y, Zhang P, Chu Q. Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies. Front Immunol 2021;12:693609. [PMID: 34194441 DOI: 10.3389/fimmu.2021.693609] [Reference Citation Analysis]
335 Safavi A, Kefayat A, Sotoodehnejadnematalahi F, Salehi M, Modarressi MH. Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine. Int Immunopharmacol 2019;76:105872. [PMID: 31499268 DOI: 10.1016/j.intimp.2019.105872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
336 Karjalainen A, Shoebridge S, Krunic M, Simonović N, Tebb G, Macho-Maschler S, Strobl B, Müller M. TYK2 in Tumor Immunosurveillance. Cancers (Basel) 2020;12:E150. [PMID: 31936322 DOI: 10.3390/cancers12010150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
337 Zhang W, Zhong W, Wang B, Yang J, Yang J, Yu Z, Qin Z, Shi A, Xu W, Zheng C, Schuchter LM, Karakousis GC, Mitchell TC, Amaravadi R, Herlyn M, Dong H, Gimotty PA, Daaboul G, Xu X, Guo W. ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression. Dev Cell 2022:S1534-5807(22)00002-8. [PMID: 35085484 DOI: 10.1016/j.devcel.2022.01.002] [Reference Citation Analysis]
338 Kohli K, Pillarisetty VG, Kim TS. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther 2021. [PMID: 33603130 DOI: 10.1038/s41417-021-00303-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
339 Sandri S, Watanabe LRM, Oliveira EA, Faião-Flores F, Migliorini S, Tiago M, Felipe-Silva A, Vazquez VL, da Costa Souza P, Consolaro MEL, Campa A, Maria-Engler SS. Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance. Pharmacol Res 2020;159:104998. [PMID: 32535222 DOI: 10.1016/j.phrs.2020.104998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
340 Khalaf K, Janowicz K, Dyszkiewicz-Konwińska M, Hutchings G, Dompe C, Moncrieff L, Jankowski M, Machnik M, Oleksiewicz U, Kocherova I, Petitte J, Mozdziak P, Shibli JA, Iżycki D, Józkowiak M, Piotrowska-Kempisty H, Skowroński MT, Antosik P, Kempisty B. CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials. Genes (Basel) 2020;11:E921. [PMID: 32796761 DOI: 10.3390/genes11080921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R, Yuan J, Rana TM. m6 A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO J 2020;39:e104514. [PMID: 32964498 DOI: 10.15252/embj.2020104514] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
342 Oya K, Nakamura Y, Zhenjie Z, Tanaka R, Okiyama N, Ichimura Y, Ishitsuka Y, Saito A, Kubota N, Watanabe R, Tahara H, Fujimoto M, Fujisawa Y. Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect. Cancers (Basel) 2021;13:3948. [PMID: 34439104 DOI: 10.3390/cancers13163948] [Reference Citation Analysis]
343 Qiu JT, Alson D, Lee TH, Tsai CC, Yu TW, Chen YS, Cheng YF, Lin CC, Schuyler SC. Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model. Cancers (Basel) 2019;11:E368. [PMID: 30875953 DOI: 10.3390/cancers11030368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
344 Yang R, Cheng S, Luo N, Gao R, Yu K, Kang B, Wang L, Zhang Q, Fang Q, Zhang L, Li C, He A, Hu X, Peng J, Ren X, Zhang Z. Distinct epigenetic features of tumor-reactive CD8+ T cells in colorectal cancer patients revealed by genome-wide DNA methylation analysis. Genome Biol. 2019;21:2. [PMID: 31892342 DOI: 10.1186/s13059-019-1921-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
345 Albekairi TH, Alshammari A, Alharbi M, Alshammary AF, Tahir ul Qamar M, Anwar T, Ismail S, Shaker B, Ahmad S. Design of a Multi-Epitope Vaccine against Tropheryma whipplei Using Immunoinformatics and Molecular Dynamics Simulation Techniques. Vaccines 2022;10:691. [DOI: 10.3390/vaccines10050691] [Reference Citation Analysis]
346 Pietrobon V, Cesano A, Marincola F, Kather JN. Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors. Front Immunol 2020;11:604967. [PMID: 33584676 DOI: 10.3389/fimmu.2020.604967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
347 Bald T, Krummel MF, Smyth MJ, Barry KC. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies. Nat Immunol 2020;21:835-47. [PMID: 32690952 DOI: 10.1038/s41590-020-0728-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
348 Huang M, Liu L, Zhu J, Jin T, Chen Y, Xu L, Cheng W, Ruan X, Su L, Meng J, Lu X, Yan F. Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer. Front Cell Dev Biol 2021;9:723817. [PMID: 34532318 DOI: 10.3389/fcell.2021.723817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Jayant K, Habib N, Huang KW, Podda M, Warwick J, Arasaradnam R. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation. Vaccines (Basel) 2020;8:E247. [PMID: 32456200 DOI: 10.3390/vaccines8020247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
350 Cai B, Liu Y, Chong Y, Zhang H, Matsunaga A, Fang X, Pacholczyk R, Zhou G, Cowell JK, Hu T. IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies. Mol Cancer 2021;20:165. [PMID: 34906138 DOI: 10.1186/s12943-021-01460-1] [Reference Citation Analysis]
351 Wang Y, Wang M, Wu HX, Xu RH. Advancing to the era of cancer immunotherapy. Cancer Commun (Lond) 2021. [PMID: 34165252 DOI: 10.1002/cac2.12178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
352 Yuan LW, Jiang XM, Xu YL, Huang MY, Chen YC, Yu WB, Su MX, Ye ZH, Chen X, Wang Y, Lu JJ. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells. Phytomedicine 2021;80:153394. [PMID: 33130472 DOI: 10.1016/j.phymed.2020.153394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
353 Del Re M, Cucchiara F, Rofi E, Fontanelli L, Petrini I, Gri N, Pasquini G, Rizzo M, Gabelloni M, Belluomini L, Crucitta S, Ciampi R, Frassoldati A, Neri E, Porta C, Danesi R. A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC. Cancer Immunol Immunother 2021;70:1667-78. [PMID: 33315149 DOI: 10.1007/s00262-020-02810-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
354 Mauseth B, Camilio KA, Shi J, Hammarström CL, Rekdal Ø, Sveinbjørnsson B, Line PD. The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma. Mol Ther Oncolytics 2019;14:139-48. [PMID: 31211244 DOI: 10.1016/j.omto.2019.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
355 Charap AJ, Enokida T, Brody R, Sfakianos J, Miles B, Bhardwaj N, Horowitz A. Landscape of natural killer cell activity in head and neck squamous cell carcinoma. J Immunother Cancer 2020;8:e001523. [PMID: 33428584 DOI: 10.1136/jitc-2020-001523] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
356 Hernandez Puente CV, Hsu PC, Rogers LJ, Jousheghany F, Siegel E, Kadlubar SA, Beck JT, Makhoul I, Hutchins LF, Kieber-Emmons T, Monzavi-Karbassi B. Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study. Front Oncol 2020;10:879. [PMID: 32582547 DOI: 10.3389/fonc.2020.00879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]